<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:41:18Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9045181" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9045181</identifier>
        <datestamp>2022-04-28</datestamp>
        <setSpec>microbiolspectr</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Microbiol Spectr</journal-id>
              <journal-id journal-id-type="iso-abbrev">Microbiol Spectr</journal-id>
              <journal-id journal-id-type="publisher-id">spectrum</journal-id>
              <journal-title-group>
                <journal-title>Microbiology Spectrum</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2165-0497</issn>
              <publisher>
                <publisher-name>American Society for Microbiology</publisher-name>
                <publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9045181</article-id>
              <article-id pub-id-type="pmcid">PMC9045181</article-id>
              <article-id pub-id-type="pmc-uid">9045181</article-id>
              <article-id pub-id-type="pmid">35348351</article-id>
              <article-id pub-id-type="pmid">35348351</article-id>
              <article-id pub-id-type="publisher-id">01626-21</article-id>
              <article-id pub-id-type="doi">10.1128/spectrum.01626-21</article-id>
              <article-id pub-id-type="publisher-id">spectrum.01626-21</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="article-attributes">
                  <compound-subject>
                    <compound-subject-part content-type="code">open-peer-review</compound-subject-part>
                    <compound-subject-part content-type="label">Open Peer Review</compound-subject-part>
                  </compound-subject>
                </subj-group>
                <subj-group subj-group-type="biological-terms">
                  <compound-subject>
                    <compound-subject-part content-type="code">clinical-microbiology</compound-subject-part>
                    <compound-subject-part content-type="label">Clinical Microbiology</compound-subject-part>
                  </compound-subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Persistent, Asymptomatic Colonization with <italic toggle="yes">Candida</italic> is Associated with Elevated Frequencies of Highly Activated Cervical Th17-Like Cells and Related Cytokines in the Reproductive Tract of South African Adolescents</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3658-8638</contrib-id>
                  <name>
                    <surname>Happel</surname>
                    <given-names>Anna-Ursula</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <email>anna.happel@uct.ac.za</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gasper</surname>
                    <given-names>Melanie</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3439-3992</contrib-id>
                  <name>
                    <surname>Balle</surname>
                    <given-names>Christina</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Konstantinus</surname>
                    <given-names>Iyaloo</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff3" ref-type="aff">
                    <sup>c</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gamieldien</surname>
                    <given-names>Hoyam</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dabee</surname>
                    <given-names>Smritee</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gill</surname>
                    <given-names>Katherine</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>d</sup>
                  </xref>
                  <!--<xref ref-type="other" rid="cr1 cr2 cr3"/>-->
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bekker</surname>
                    <given-names>Linda-Gail</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>d</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Passmore</surname>
                    <given-names>Jo-Ann S.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff5" ref-type="aff">
                    <sup>e</sup>
                  </xref>
                  <xref rid="aff6" ref-type="aff">
                    <sup>f</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0745-6073</contrib-id>
                  <name>
                    <surname>Jaspan</surname>
                    <given-names>Heather B.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                  <xref rid="aff7" ref-type="aff">
                    <sup>g</sup>
                  </xref>
                </contrib>
                <aff id="aff1">
                  <label>a</label>
                  <addr-line>Department of Pathology, Institute of Infectious Disease and Molecular Medicine, <institution-wrap><institution>University of Cape Town</institution><institution-id institution-id-type="grid">grid.7836.a</institution-id></institution-wrap>, Cape Town, South Africa</addr-line>
                </aff>
                <aff id="aff2">
                  <label>b</label>
                  <addr-line>Seattle Children’s Research Institute, Seattle, Washington, USA</addr-line>
                </aff>
                <aff id="aff3">
                  <label>c</label>
                  <addr-line>Namibia Institute of Pathology, Windhoek, Namibia</addr-line>
                </aff>
                <aff id="aff4">
                  <label>d</label>
                  <addr-line>Desmond Tutu HIV Centre, <institution-wrap><institution>University of Cape Town</institution><institution-id institution-id-type="grid">grid.7836.a</institution-id></institution-wrap>, Cape Town, South Africa</addr-line>
                </aff>
                <aff id="aff5">
                  <label>e</label>
                  <addr-line>DST-NRF CAPRISA Centre of Excellence in HIV Prevention, Cape Town, South Africa</addr-line>
                </aff>
                <aff id="aff6">
                  <label>f</label>
                  <addr-line>National Health Laboratory Service, Cape Town, South Africa</addr-line>
                </aff>
                <aff id="aff7">
                  <label>g</label>
                  <addr-line>Department of Pediatrics and Global Health, University of Washington, Seattle, Washington, USA</addr-line>
                </aff>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <role>Editor</role>
                  <name>
                    <surname>Coelho</surname>
                    <given-names>Carolina</given-names>
                  </name>
                  <aff>University of Exeter</aff>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="reviewer">
                  <name>
                    <surname>Cai</surname>
                    <given-names>Catherine</given-names>
                  </name>
                  <role>ad hoc peer reviewer</role>
                  <aff>Saint Louis University</aff>
                </contrib>
                <contrib contrib-type="reviewer">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0843-7739</contrib-id>
                  <name>
                    <surname>Chen</surname>
                    <given-names>Peigen</given-names>
                  </name>
                  <role>ad hoc peer reviewer</role>
                  <aff>Sixth Affiliated Hospital of Sun Yat-Sen University</aff>
                </contrib>
              </contrib-group>
              <author-notes>
                <fn fn-type="COI-statement">
                  <p>The authors declare no conflict of interest.</p>
                </fn>
              </author-notes>
              <pub-date publication-format="electronic" date-type="pub">
                <day>29</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date publication-format="electronic" date-type="collection">
                <season>Mar-Apr</season>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>29</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>10</volume>
              <issue>2</issue>
              <elocation-id>e01626-21</elocation-id>
              <history>
                <date date-type="received">
                  <day>20</day>
                  <month>9</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>25</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2022 Happel et al.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Happel et al.</copyright-holder>
                <ali:free_to_read start_date="2022-03-29"/>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="spectrum.01626-21.pdf"/>
              <self-uri content-type="reviewer_comments" xlink:href="reviewer-comments.pdf"/>
              <abstract>
                <title>ABSTRACT</title>
                <p>Cervicovaginal inflammation, nonoptimal microbiota, T-cell activation, and hormonal contraceptives may increase HIV risk, yet associations between these factors and subclinical <italic toggle="yes">Candida</italic> colonization or hyphae are unknown. We collected cervicovaginal samples from 94 South African adolescents, aged 15 to 19 years, who were randomized to injectable norethisterone enanthate (Net-En), an etonorgesterol/ethinyl estradiol vaginal ring (NuvaRing), or oral contraceptives in the UChoose trial (NCT02404038) at baseline and 16 weeks post-randomization. We assessed cervicovaginal samples for subclinical <italic toggle="yes">Candida</italic> colonization (by quantitative PCR [qPCR]), hyphae (by Gram stain), microbiota composition (by 16S rRNA gene sequencing), cytokine concentrations (by Luminex), and cervical T-cell phenotypes and activation (by multiparameter flow cytometry). While hormonal contraceptive type did not influence incidence of <italic toggle="yes">Candida</italic> colonization or hyphae, hyphae presence was associated with significantly elevated concentrations of IL-22, IL-17A and IL-17F, all produced by Th17 cells, but not of other cytokines, such as IL-1β or IL-6, after adjustment for confounders. Subclinical <italic toggle="yes">Candida</italic> colonization was associated with reduced frequencies of Th17-like cells and elevated frequencies of CCR6-CCR10 T cells. Women with <italic toggle="yes">Candida</italic> hyphae were less likely to have bacterial vaginosis (BV). Persistent, subclinical colonization with <italic toggle="yes">Candida</italic> over 16 weeks was associated with significant increases in Th17-related cytokine concentrations and highly activated Th17-like and CCR6-CCR10 T-cell frequencies. These data suggest that vaginal <italic toggle="yes">Candida</italic> colonization and hyphae increase Th17-related cytokines, but not overall female genital tract inflammation in Sub-Saharan African adolescents. Persistent <italic toggle="yes">Candida</italic> colonization, even when asymptomatic, may increase Th17 cell frequencies and related cytokines and thereby could subsequently increase HIV risk, although the causal relationship requires confirmation.</p>
                <p><bold>IMPORTANCE</bold> Sub-Saharan African female adolescents are globally at the highest risk of HIV acquisition, and genital inflammation, microbial dysbiosis, and cervical HIV target cell activation are thought to contribute to this risk. Previously, the relationship between these mucosal factors and subclinical vaginal <italic toggle="yes">Candida</italic> colonization or hyphae has not been described, and the role of HIV-susceptible Th17 cells in mediating anti-<italic toggle="yes">Candida</italic> immunity in the human female genital tract has not been clearly established. We show that presence of yeast hyphae was associated with increases in Th17 cell-related cytokines and the absence of microbial dysbiosis, and that persistent <italic toggle="yes">Candida</italic> colonization resulted in significant increases in Th17-related cytokines and highly activated Th17-like cell frequencies. Our results suggest that Th17 cells are important for anti-<italic toggle="yes">Candida</italic> immunity in the human female genital tract and that prolonged vaginal <italic toggle="yes">Candida</italic> colonization may contribute to increased HIV risk in Sub-Saharan African adolescents by increasing HIV target cell frequencies and activation.</p>
              </abstract>
              <kwd-group>
                <title>KEYWORDS</title>
                <kwd>vaginal candidiasis</kwd>
                <kwd>Sub-Saharan Africa</kwd>
                <kwd>genital inflammation</kwd>
                <kwd>HIV target cells</kwd>
                <kwd>mucosal immunity</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group award-type="grant" id="award1">
                  <funding-source id="GS1">
                    <institution-wrap>
                      <institution>HHS | National Institutes of Health (NIH)</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 HD083040</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Passmore</surname>
                      <given-names>Jo-Ann S.</given-names>
                    </name>
                  </principal-award-recipient>
                  <principal-award-recipient>
                    <name>
                      <surname>Jaspan</surname>
                      <given-names>Heather B.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <counts>
                <count count="1" count-type="supplementary-material"/>
                <fig-count count="7"/>
                <table-count count="1"/>
                <equation-count count="0"/>
                <ref-count count="59"/>
                <page-count count="18"/>
                <word-count count="10748"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>March/April 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="s1">
              <title>INTRODUCTION</title>
              <p>Young women in Sub-Saharan Africa are disproportionally affected by HIV (<xref rid="B1" ref-type="bibr">1</xref>) and observational studies have implicated certain hormonal contraceptive types (<xref rid="B2" ref-type="bibr">2</xref>) and potentially colonization with vulvovaginal <italic toggle="yes">Candida</italic> (evident by Gram stain) (<xref rid="B3" ref-type="bibr">3</xref>) with increased HIV risk in women. In addition, cervicovaginal inflammation has been associated with an increased risk of HIV acquisition (<xref rid="B4" ref-type="bibr">4</xref>) through increased numbers and activation of specific cervical HIV target cell phenotypes (<xref rid="B5" ref-type="bibr">5</xref>). The major drivers of cervicovaginal inflammation include colonization with nonoptimal bacterial microbiota (<xref rid="B6" ref-type="bibr">6</xref>) and the presence of undiagnosed or asymptomatic sexually transmitted infections (STIs) (<xref rid="B7" ref-type="bibr">7</xref>). The relationship between these cervicovaginal factors and <italic toggle="yes">Candida</italic> colonization or vulvovaginal candidiasis (VVC) has not been described. Furthermore, it has not been investigated whether hormonal contraceptive type influences incidence of <italic toggle="yes">Candida</italic> colonization or VVC in adolescents at a high risk of HIV acquisition.</p>
              <p>The majority of women experience asymptomatic vaginal <italic toggle="yes">Candida</italic> colonization at some point during their lives (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>), and it is thought that vaginal defense mechanisms against <italic toggle="yes">Candida</italic> spp. allow for their persistence as commensals (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B10" ref-type="bibr">10</xref>). When anti-fungal host defenses do not respond adequately or changes in the host environment occur, opportunistic <italic toggle="yes">Candida</italic> spp. can transform from a symptomless colonization into a pathogenic infection, which is accompanied by the presence of budding yeasts and a morphological transition from yeast cells to hyphae, which may result in symptomatic VVC (<xref rid="B10" ref-type="bibr">10</xref>). VVC is defined by clinical signs and symptoms of vulvovaginal inflammation, with the presence of budding yeasts, hyphae, or pseudohyphae on a wet mount or Gram stain (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>). Interleukin (IL)-17-mediated responses have been shown to be essential in controlling clinical cases of candidiasis at the oral and dermal mucosae (<xref rid="B11" ref-type="bibr">11</xref>), although its role in anti-<italic toggle="yes">Candida</italic> immunity in the human female genital tract (FGT) has not been clearly established. Studies in some mouse models have suggested that IL-17 responses were protective against murine VVC (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). However, other studies have found that mice lacking the IL-17/IL-22 signaling pathway showed no evidence of altered VVC susceptibility or immunopathology (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). An experimental <named-content content-type="genus-species">C. albicans</named-content> vaccine administered to mice demonstrated a moderate increased time to VVC recurrence that was associated with vaccine-enhanced T-helper 1 (Th1) and T-helper 17 (Th17) responses (<xref rid="B15" ref-type="bibr">15</xref>). Th17 cells mediate protection by producing IL-17A, IL-17F, IL-21, and IL-22 (<xref rid="B16" ref-type="bibr">16</xref>), while Th1 cells produce IL-1β, IL-2, IL-12, tumor necrosis factor (TNF)-α, and IFN-γ (<xref rid="B17" ref-type="bibr">17</xref>), but both are thought to be highly susceptible to HIV infection, especially in their activated state (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). Thus, activation of host defenses against vaginal <italic toggle="yes">Candida</italic> colonization or infection in the human FGT may result in increased genital pro-inflammatory cytokine production and enrichment for Th1/Th17 cells, both of which have been linked to an increased risk of HIV acquisition (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>).</p>
              <p>FGT inflammation and Th1/Th17 cell phenotype and activation are also influenced by hormonal contraceptive type (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>), and previous observational studies have suggested that hormonal contraceptive type may influence <italic toggle="yes">Candida</italic> colonization, with hormonal contraceptive users experiencing higher <italic toggle="yes">Candida</italic> prevalence than non-users (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). The prevalence of asymptomatic vaginal <italic toggle="yes">Candida</italic> colonization and symptomatic VVC has been found to be 2-fold higher in women taking combined oral contraceptives (COC) compared to those using other barrier and hormonal contraceptives (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). A higher prevalence of <italic toggle="yes">Candida</italic> colonization and VVC has also been found in intrauterine device (IUD) users compared to that in women not using IUDs (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Further, contraceptive vaginal rings like the NuvaRing (<xref rid="B28" ref-type="bibr">28</xref>), a novel etonorgesterol/ethinyl estradiol combined contraceptive ring inserted monthly, have been shown <italic toggle="yes">in vitro</italic> to be easily colonized by <italic toggle="yes">Candida</italic> spp., and there is clinical evidence that NuvaRing use is associated with high incidence of <italic toggle="yes">Candida</italic> colonization (<xref rid="B29" ref-type="bibr">29</xref>). However, there are limited data on the effect of hormonal contraceptive type on incidence of <italic toggle="yes">Candida</italic> colonization or hyphae formation in adolescents.</p>
              <p>In a longitudinal open-label study that randomized South African adolescents to the injectable norethisterone enanthate (Net-En), COC or NuvaRing, we hypothesized that NuvaRing use is associated with increased vaginal colonization with <italic toggle="yes">Candida</italic> spp. compared to COC and Net-En use in Sub-Saharan adolescents at high risk of HIV acquisition, and that it would consequently be associated with increased genital inflammation, higher frequencies and activation of Th17- and Th1-enriched cells, and nonoptimal vaginal microbiota.</p>
            </sec>
            <sec sec-type="results" id="s2">
              <title>RESULTS</title>
              <p><bold>Cohort characteristics.</bold> Of the 130 enrolled participants, 94 adolescents (median, 17 years old; interquartile range [IQR], 16 to 18 years) who were randomized to Net-En (<italic toggle="yes">n</italic> = 32), NuvaRing (<italic toggle="yes">n</italic> = 30), and COC (<italic toggle="yes">n</italic> = 32) completed the 16-week follow-up visit and had samples available for <italic toggle="yes">Candida</italic> assessment at the baseline and 16-week follow-up time points. The CONSORT diagram of the number of participants who completed each study visit and provided genital samples has been published previously (<xref rid="B20" ref-type="bibr">20</xref>). There were no differences in demographics, vaginal insertion practices, risk behavior, or baseline prevalence of bacterial vaginosis (BV) or STIs by randomization arm, as previously described (<xref rid="B20" ref-type="bibr">20</xref>). At baseline, 52 participants (55.3%) had evidence of <italic toggle="yes">Candida</italic> colonization by quantitative PCR (qPCR), while 12 participants (12.8%) had evidence of yeast hyphae by Gram stain, which is indicative of a more pathogenic <italic toggle="yes">Candida</italic> infection. Importantly, none of these adolescents reported any vaginal symptoms. When participants were binarized into ‘high’ and ‘low’ <italic toggle="yes">Candida</italic> colonization groups based on the median quantitative PCR cycle threshold (<italic toggle="yes">C<sub>T</sub></italic>) value, all but two participants with hypha formation at baseline showed evidence of high <italic toggle="yes">Candida</italic> colonization (10/12; 83.3%).</p>
              <p>Prevalence of STIs and most captured sexual behaviors did not differ significantly between adolescents with evidence of vaginal <italic toggle="yes">Candida</italic> colonization compared to those without at baseline, nor did current contraceptive use or contraceptive randomization arm (<xref rid="tab1" ref-type="table">Table 1</xref>). Adolescents with <italic toggle="yes">Candida</italic> colonization more commonly reported ‘almost always’ or ‘always’ using condoms (79.9% versus 55.9%; <italic toggle="yes">P</italic> = 0.027) compared to those without <italic toggle="yes">Candida</italic> colonization, consistent with results of previous literature (<xref rid="B10" ref-type="bibr">10</xref>). The prevalence of <italic toggle="yes">N. gonorrheae</italic> was 4-fold higher in adolescents with high <italic toggle="yes">Candida</italic> colonization (7/23; 30.4%) compared to those with low (2/29, 6.9%, <italic toggle="yes">P</italic> = 0.035) or no colonization (2/35, 8.6%, <italic toggle="yes">P</italic> = 0.011) (<xref rid="tab1" ref-type="table">Table 1</xref>). Since STIs are highly inflammatory (<xref rid="B7" ref-type="bibr">7</xref>) and may confound the relationship between <italic toggle="yes">Candida</italic> colonization and cervicovaginal cytokines or T-cell phenotypes, we adjusted for their presence in subsequent analyses, alongside Herpes simplex virus (HSV)-2 seropositivity and BV.</p>
              <table-wrap position="float" id="tab1">
                <label>TABLE 1</label>
                <caption>
                  <p>Biological, demographic, and behavioral baseline characteristics in women with <italic toggle="yes">Candida</italic> colonization and VVC compared to those without<xref rid="ngtab1-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></p>
                </caption>
                <alternatives>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                      <col span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1">Characteristic<named-content content-type="genus-species">; N (%)</named-content><xref rid="ngtab1-2" ref-type="table-fn"><sup><italic toggle="yes">b</italic></sup></xref></th>
                        <th rowspan="1" colspan="1">None (<italic toggle="yes">n</italic> = 35)</th>
                        <th rowspan="1" colspan="1">Colonization (<italic toggle="yes">n</italic> = 52)</th>
                        <th rowspan="1" colspan="1">
                          <italic toggle="yes">P</italic>
                        </th>
                        <th rowspan="1" colspan="1">High colonization (<italic toggle="yes">n</italic> = 23)</th>
                        <th rowspan="1" colspan="1">Low colonization (<italic toggle="yes">n</italic> = 29)</th>
                        <th rowspan="1" colspan="1">
                          <italic toggle="yes">P</italic>
                          <xref rid="ngtab1-3" ref-type="table-fn">
                            <sup>
                              <italic toggle="yes">c</italic>
                            </sup>
                          </xref>
                        </th>
                        <th rowspan="1" colspan="1">None (<italic toggle="yes">n</italic> = 75)</th>
                        <th rowspan="1" colspan="1">Hypha formation (<italic toggle="yes">n</italic> = 12)</th>
                        <th rowspan="1" colspan="1">
                          <italic toggle="yes">P</italic>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Age; median (IQR)</td>
                        <td rowspan="1" colspan="1">17 (16–18)</td>
                        <td rowspan="1" colspan="1">17 (16–18)</td>
                        <td rowspan="1" colspan="1">0.471</td>
                        <td rowspan="1" colspan="1">17 (16–18)</td>
                        <td rowspan="1" colspan="1">18 (16–18)</td>
                        <td rowspan="1" colspan="1">0.767</td>
                        <td rowspan="1" colspan="1">17 (16–18)</td>
                        <td rowspan="1" colspan="1">17 (16–18)</td>
                        <td rowspan="1" colspan="1">0.678</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Species</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <named-content content-type="genus-species"> C. trachomatis</named-content>
                        </td>
                        <td rowspan="1" colspan="1">15 (42.9)</td>
                        <td rowspan="1" colspan="1">17 (32.7)</td>
                        <td rowspan="1" colspan="1">0.461</td>
                        <td rowspan="1" colspan="1">11 (47.8)</td>
                        <td rowspan="1" colspan="1">6 (20.7)</td>
                        <td rowspan="1" colspan="1">0.082</td>
                        <td rowspan="1" colspan="1">27 (36.0)</td>
                        <td rowspan="1" colspan="1">5 (41.7)</td>
                        <td rowspan="1" colspan="1">0.956</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <named-content content-type="genus-species"> N. gonorrhoea</named-content>
                        </td>
                        <td rowspan="1" colspan="1">3 (8.6)</td>
                        <td rowspan="1" colspan="1">9 (17.3)</td>
                        <td rowspan="1" colspan="1">0.400</td>
                        <td rowspan="1" colspan="1">7 (30.4)</td>
                        <td rowspan="1" colspan="1">2 (6.9)</td>
                        <td style="color:#000000 000000" rowspan="1" colspan="1">
                          <bold>0.026</bold>
                        </td>
                        <td rowspan="1" colspan="1">9 (12.0)</td>
                        <td rowspan="1" colspan="1">3 (25.0)</td>
                        <td rowspan="1" colspan="1">0.446</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <named-content content-type="genus-species"> T. vaginalis</named-content>
                        </td>
                        <td rowspan="1" colspan="1">3 (8.6)</td>
                        <td rowspan="1" colspan="1">6 (11.5)</td>
                        <td rowspan="1" colspan="1">0.931</td>
                        <td rowspan="1" colspan="1">2 (8.7)</td>
                        <td rowspan="1" colspan="1">4 (13.8)</td>
                        <td rowspan="1" colspan="1">0.757</td>
                        <td rowspan="1" colspan="1">8 (10.7)</td>
                        <td rowspan="1" colspan="1">1 (8.3)</td>
                        <td rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <named-content content-type="genus-species"> M. genitalium</named-content>
                        </td>
                        <td rowspan="1" colspan="1">2 (5.7)</td>
                        <td rowspan="1" colspan="1">1 (1.9)</td>
                        <td rowspan="1" colspan="1">0.725</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1 (3.4)</td>
                        <td rowspan="1" colspan="1">0.506</td>
                        <td rowspan="1" colspan="1">3 (4.0)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">BV</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.683</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.674</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">
                          <bold>0.038</bold>
                        </td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Negative</td>
                        <td rowspan="1" colspan="1">19 (54.3)</td>
                        <td rowspan="1" colspan="1">24 (46.2)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">11 (47.8)</td>
                        <td rowspan="1" colspan="1">13 (44.8)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">33 (44.0)</td>
                        <td rowspan="1" colspan="1">10 (83.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Intermediate</td>
                        <td rowspan="1" colspan="1">2 (5.7)</td>
                        <td rowspan="1" colspan="1">5 (9.6)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">1 (4.3)</td>
                        <td rowspan="1" colspan="1">4 (13.8)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">7 (9.3)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Positive</td>
                        <td rowspan="1" colspan="1">14 (40.0)</td>
                        <td rowspan="1" colspan="1">23 (44.2)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">11 (47.8)</td>
                        <td rowspan="1" colspan="1">12 (41.4)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">35 (46.7)</td>
                        <td rowspan="1" colspan="1">2 (16.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">HSV-2 serology</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.657</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.515</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.536</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Negative</td>
                        <td rowspan="1" colspan="1">24 (68.6)</td>
                        <td rowspan="1" colspan="1">37 (71.2)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">15 (65.2)</td>
                        <td rowspan="1" colspan="1">22 (75.9)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">54 (72.0)</td>
                        <td rowspan="1" colspan="1">7 (58.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Positive</td>
                        <td rowspan="1" colspan="1">11 (31.4)</td>
                        <td rowspan="1" colspan="1">14 (26.9)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">8 (34.8)</td>
                        <td rowspan="1" colspan="1">6 (20.7)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">20 (26.7)</td>
                        <td rowspan="1" colspan="1">5 (41.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Equivocal</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1 (1.9)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1 (3.4)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">1 (1.3)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Vaginal pH; mean (SD)</td>
                        <td rowspan="1" colspan="1">4.8 (0.6)</td>
                        <td rowspan="1" colspan="1">4.9 (0.5)</td>
                        <td rowspan="1" colspan="1">0.351</td>
                        <td rowspan="1" colspan="1">4.9 (0.5)</td>
                        <td rowspan="1" colspan="1">4.9 (0.5)</td>
                        <td rowspan="1" colspan="1">0.506</td>
                        <td rowspan="1" colspan="1">4.9 (0.5)</td>
                        <td rowspan="1" colspan="1">4.7 (0.7)</td>
                        <td rowspan="1" colspan="1">0.334</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">CST distribution<xref rid="ngtab1-4" ref-type="table-fn"><sup><italic toggle="yes">d</italic></sup></xref></td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.435</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.450</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.101</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> CST-I</td>
                        <td rowspan="1" colspan="1">10 (29.4)</td>
                        <td rowspan="1" colspan="1">10 (19.6)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">6 (23.1)</td>
                        <td rowspan="1" colspan="1">4 (16.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">16 (21.9)</td>
                        <td rowspan="1" colspan="1">4 (33.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> CST-III</td>
                        <td rowspan="1" colspan="1">6 (17.6)</td>
                        <td rowspan="1" colspan="1">14 (27.5)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">5 (19.2)</td>
                        <td rowspan="1" colspan="1">9 (36.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">15 (20.5)</td>
                        <td rowspan="1" colspan="1">5 (41.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> CST-IV</td>
                        <td rowspan="1" colspan="1">18 (52.9)</td>
                        <td rowspan="1" colspan="1">27 (52.9)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">15 (57.7)</td>
                        <td rowspan="1" colspan="1">12 (48.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">42 (57.5)</td>
                        <td rowspan="1" colspan="1">3 (25.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Shannon index; median (IQR)</td>
                        <td rowspan="1" colspan="1">1.53 (0.43–2.14)</td>
                        <td rowspan="1" colspan="1">1.46 (0.69–2.11)</td>
                        <td rowspan="1" colspan="1">0.914</td>
                        <td rowspan="1" colspan="1">1.50 (0.70–2.18)</td>
                        <td rowspan="1" colspan="1">1.45 (0.72–1.94)</td>
                        <td rowspan="1" colspan="1">0.863</td>
                        <td rowspan="1" colspan="1">1.70 (0.54–2.17)</td>
                        <td rowspan="1" colspan="1">0.83 (0.54–1.46)</td>
                        <td rowspan="1" colspan="1">0.211</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">High genital cytokines<xref rid="ngtab1-5" ref-type="table-fn"><sup><italic toggle="yes">e</italic></sup></xref></td>
                        <td rowspan="1" colspan="1">21 (60.0)</td>
                        <td rowspan="1" colspan="1">33 (63.5)</td>
                        <td rowspan="1" colspan="1">0.892</td>
                        <td rowspan="1" colspan="1">14 (60.9)</td>
                        <td rowspan="1" colspan="1">19 (65.5)</td>
                        <td rowspan="1" colspan="1">0.866</td>
                        <td rowspan="1" colspan="1">48 (64.0)</td>
                        <td rowspan="1" colspan="1">6 (50.0)</td>
                        <td rowspan="1" colspan="1">0.591</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Current contraceptive use</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.246</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.123</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.292</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> COC</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">4 (15.4)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">4 (15.4)</td>
                        <td rowspan="1" colspan="1">0 0.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">2 (2.7)</td>
                        <td rowspan="1" colspan="1">2 (16.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> DMPA</td>
                        <td rowspan="1" colspan="1">7 (20.0)</td>
                        <td rowspan="1" colspan="1">8 (16.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">4 (15.4)</td>
                        <td rowspan="1" colspan="1">4 (16.7)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">13 (17.8)</td>
                        <td rowspan="1" colspan="1">2 (16.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Implanon</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">3 (6.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">2 (7.7)</td>
                        <td rowspan="1" colspan="1">1 (4.2)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">3 (4.1)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Net-En</td>
                        <td rowspan="1" colspan="1">20 (57.1)</td>
                        <td rowspan="1" colspan="1">24 (48.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">11 (42.3)</td>
                        <td rowspan="1" colspan="1">13 (54.2)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">38 (52.1)</td>
                        <td rowspan="1" colspan="1">6 (50.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> None</td>
                        <td rowspan="1" colspan="1">8 (22.9)</td>
                        <td rowspan="1" colspan="1">11 (22.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">5 (19.2)</td>
                        <td rowspan="1" colspan="1">6 (25.0)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">17 (23.3)</td>
                        <td rowspan="1" colspan="1">2 (16.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Contraceptive randomization arm</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.830</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.975</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.294</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> COC</td>
                        <td rowspan="1" colspan="1">10 (28.6)</td>
                        <td rowspan="1" colspan="1">18 (34.6)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">9 (34.6)</td>
                        <td rowspan="1" colspan="1">9 (34.6)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">24 (32.0)</td>
                        <td rowspan="1" colspan="1">4 (33.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Net-En</td>
                        <td rowspan="1" colspan="1">13 (37.1)</td>
                        <td rowspan="1" colspan="1">17 (32.7)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">9 (34.6)</td>
                        <td rowspan="1" colspan="1">8 (30.8)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">28 (37.3)</td>
                        <td rowspan="1" colspan="1">2 (16.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> NuvaRing</td>
                        <td rowspan="1" colspan="1">12 (34.3)</td>
                        <td rowspan="1" colspan="1">17 (32.7)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">8 (30.8)</td>
                        <td rowspan="1" colspan="1">9 (34.6)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">23 (30.7)</td>
                        <td rowspan="1" colspan="1">6 (50.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Previous pregnancy</td>
                        <td rowspan="1" colspan="1">7 (20.0)</td>
                        <td rowspan="1" colspan="1">5 (9.8)</td>
                        <td rowspan="1" colspan="1">0.306</td>
                        <td rowspan="1" colspan="1">1 (4.5)</td>
                        <td rowspan="1" colspan="1">4 (13.8)</td>
                        <td rowspan="1" colspan="1">0.261</td>
                        <td rowspan="1" colspan="1">11 (14.9)</td>
                        <td rowspan="1" colspan="1">1 (8.3)</td>
                        <td rowspan="1" colspan="1">0.876</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Vaginal douching</td>
                        <td rowspan="1" colspan="1">1 (2.9)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0.849</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0.478</td>
                        <td rowspan="1" colspan="1">1 (1.4)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Intravaginal practices</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Wash with water</td>
                        <td rowspan="1" colspan="1">6 (17.1)</td>
                        <td rowspan="1" colspan="1">7 (13.7)</td>
                        <td rowspan="1" colspan="1">0.898</td>
                        <td rowspan="1" colspan="1">2 (8.7)</td>
                        <td rowspan="1" colspan="1">5 (17.9)</td>
                        <td rowspan="1" colspan="1">0.602</td>
                        <td rowspan="1" colspan="1">12 (16.2)</td>
                        <td rowspan="1" colspan="1">1 (8.3)</td>
                        <td rowspan="1" colspan="1">0.785</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Insert herbs</td>
                        <td rowspan="1" colspan="1">1 (2.9)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0.849</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0.478</td>
                        <td rowspan="1" colspan="1">1 (1.4)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Insert cloth</td>
                        <td rowspan="1" colspan="1">2 (5.7)</td>
                        <td rowspan="1" colspan="1">2 (3.9)</td>
                        <td rowspan="1" colspan="1">1.000</td>
                        <td rowspan="1" colspan="1">1 (4.3)</td>
                        <td rowspan="1" colspan="1">1 (3.6)</td>
                        <td rowspan="1" colspan="1">0.920</td>
                        <td rowspan="1" colspan="1">4 (5.4)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0.932</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Insert medication</td>
                        <td rowspan="1" colspan="1">2 (5.7)</td>
                        <td rowspan="1" colspan="1">1 (2.0)</td>
                        <td rowspan="1" colspan="1">0.738</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1 (3.6)</td>
                        <td rowspan="1" colspan="1">0.510</td>
                        <td rowspan="1" colspan="1">3 (4.1)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Tampon use</td>
                        <td rowspan="1" colspan="1">2 (5.7)</td>
                        <td rowspan="1" colspan="1">4 (7.8)</td>
                        <td rowspan="1" colspan="1">1.000</td>
                        <td rowspan="1" colspan="1">1 (4.3)</td>
                        <td rowspan="1" colspan="1">3 (10.7)</td>
                        <td rowspan="1" colspan="1">0.627</td>
                        <td rowspan="1" colspan="1">6 (8.1)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">0.680</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Current sexual partner</td>
                        <td rowspan="1" colspan="1">34 (100.0)</td>
                        <td rowspan="1" colspan="1">47 (90.4)</td>
                        <td rowspan="1" colspan="1">0.164</td>
                        <td rowspan="1" colspan="1">21 (91.3)</td>
                        <td rowspan="1" colspan="1">26 (89.7)</td>
                        <td rowspan="1" colspan="1">0.171</td>
                        <td rowspan="1" colspan="1">69 (93.2)</td>
                        <td rowspan="1" colspan="1">12 (100.0)</td>
                        <td rowspan="1" colspan="1">0.793</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">General condom use</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.068</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.218</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.958</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Never</td>
                        <td rowspan="1" colspan="1">3 (8.8)</td>
                        <td rowspan="1" colspan="1">6 (11.5)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">2 (8.7)</td>
                        <td rowspan="1" colspan="1">4 (13.8)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">7 (9.5)</td>
                        <td rowspan="1" colspan="1">2 (16.7)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Almost never</td>
                        <td rowspan="1" colspan="1">5 (14.7)</td>
                        <td rowspan="1" colspan="1">4 (7.7)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">2 (8.7)</td>
                        <td rowspan="1" colspan="1">2 (6.9)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">8 (10.8)</td>
                        <td rowspan="1" colspan="1">1 (8.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Not sure</td>
                        <td rowspan="1" colspan="1">7 (20.6)</td>
                        <td rowspan="1" colspan="1">2 (3.8)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">1 (4.3)</td>
                        <td rowspan="1" colspan="1">1 (3.4)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">8 (10.8)</td>
                        <td rowspan="1" colspan="1">1 (8.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Almost always</td>
                        <td rowspan="1" colspan="1">8 (23.5)</td>
                        <td rowspan="1" colspan="1">22 (42.3)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">8 (34.8)</td>
                        <td rowspan="1" colspan="1">14 (48.3)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">26 (35.1)</td>
                        <td rowspan="1" colspan="1">4 (33.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Always</td>
                        <td rowspan="1" colspan="1">11 (32.4)</td>
                        <td rowspan="1" colspan="1">18 (34.6)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">10 (43.5)</td>
                        <td rowspan="1" colspan="1">8 (27.6)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">25 (33.8)</td>
                        <td rowspan="1" colspan="1">4 (33.3)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Sex with ≥5 yrs older partner</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.379</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.325</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.242</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> No</td>
                        <td rowspan="1" colspan="1">9 (26.5)</td>
                        <td rowspan="1" colspan="1">24 (46.2)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">10 (43.5)</td>
                        <td rowspan="1" colspan="1">14 (48.3)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">27 (36.5)</td>
                        <td rowspan="1" colspan="1">6 (50.0)</td>
                        <td rowspan="1" colspan="1">0.242</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Don’t think so</td>
                        <td rowspan="1" colspan="1">3 (8.8)</td>
                        <td rowspan="1" colspan="1">3 (5.8)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">1 (4.3)</td>
                        <td rowspan="1" colspan="1">2 (6.9)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">6 8.1)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Not sure</td>
                        <td rowspan="1" colspan="1">14 (41.2)</td>
                        <td rowspan="1" colspan="1">15 (28.8)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">10 (43.5)</td>
                        <td rowspan="1" colspan="1">5 (17.2)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">23 (31.1)</td>
                        <td rowspan="1" colspan="1">6 (50.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> I think so</td>
                        <td rowspan="1" colspan="1">2 (5.9)</td>
                        <td rowspan="1" colspan="1">1 (1.9)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1">1 (3.4)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">3 (4.1)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Yes</td>
                        <td rowspan="1" colspan="1">6 (17.6)</td>
                        <td rowspan="1" colspan="1">9 (17.3)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">2 (8.7)</td>
                        <td rowspan="1" colspan="1">7 (24.1)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">15 (20.3)</td>
                        <td rowspan="1" colspan="1">0 (0.0)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <graphic xlink:href="spectrum.01626-21_t001" position="anchor"/>
                </alternatives>
                <table-wrap-foot>
                  <fn fn-type="other" id="ngtab1-1">
                    <label>a</label>
                    <p>BV, bacterial vaginosis; COC, combined oral contraceptives; IQR, interquartile range; SD, standard deviation; CST, community state type.</p>
                  </fn>
                  <fn fn-type="other" id="ngtab1-2">
                    <label>b</label>
                    <p>Unless otherwise specified.</p>
                  </fn>
                  <fn fn-type="other" id="ngtab1-3">
                    <label>c</label>
                    <p>Comparing no, low, and high colonization. Values in bold font are statistically significant.</p>
                  </fn>
                  <fn fn-type="other" id="ngtab1-4">
                    <label>d</label>
                    <p>Based on vaginal bacterial microbiota assessment by 16S rRNA gene sequencing (Balle et al. [<xref rid="B20" ref-type="bibr">20</xref>]). CST-I = <named-content content-type="genus-species">L. crispatus</named-content>-dominated, low diversity; CST-III = <italic toggle="yes">L. iners</italic>-dominated, low diversity; CST-IV = diverse groups of anaerobic BV-associated bacteria, high diversity.</p>
                  </fn>
                  <fn fn-type="other" id="ngtab1-5">
                    <label>e</label>
                    <p>Based on genital cytokine measurements by Luminex (Konstantinus et al. [<xref rid="B21" ref-type="bibr">21</xref>]; Balle et al. [<xref rid="B20" ref-type="bibr">20</xref>]). Unsupervised PAM clustering of cytokine concentrations was used to binarize overall cervicovaginal cytokines levels into ‘cervicovaginal cytokines–high’ and ‘cervicovaginal cytokines –low’ clusters.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p><bold><italic toggle="yes">Candida</italic> colonization and cervicovaginal cytokines.</bold> We previously used unsupervised partition around medoids (PAM) clustering to binarize participants of this cohort into genital cytokine–high and genital cytokine–low clusters based on their overall cytokine profile (<xref rid="B20" ref-type="bibr">20</xref>). At baseline, neither <italic toggle="yes">Candida</italic> colonization nor the presence of yeast hyphae drove overall genital tract cytokine status in these South African adolescents, but BV did (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). About 60% of adolescents had highly elevated genital tract cytokine concentrations, but this did not differ by <italic toggle="yes">Candida</italic> colonization or hyphae presence status (<xref rid="tab1" ref-type="table">Table 1</xref>).</p>
              <fig position="float" id="fig1">
                <label>FIG 1</label>
                <caption>
                  <p><italic toggle="yes">Candida</italic> colonization cervicovaginal cytokines at baseline. (A) Heatmap of log<sub>10</sub> cytokine concentrations at baseline annotated by cytokine/inflammatory group, bacterial vaginosis (BV) status by Nugent Scoring, presence of bacterial sexually transmitted infections (STIs), yeast hyphae (hyphae) by Gram stain, and <italic toggle="yes">Candida</italic> colonization by qPCR. (B) Multivariate linear regressions showing the association between genital cytokine concentrations in women with low or high <italic toggle="yes">Candida</italic> colonization compared to those without any colonization, and in women with hyphae compared to those without. Each association is shown as a β-coefficient and the error bars represent the 95% confidence interval (CI). Associations shown in purple are statistically significant. <italic toggle="yes">P</italic> values of ≤0.05 were considered statistically significant.</p>
                </caption>
                <graphic xlink:href="spectrum.01626-21-f001" position="float"/>
              </fig>
              <p>In univariate analyses, women with hypha formation at baseline had higher cervicovaginal concentrations of IL-22 (median, 12.79 pg/mL; IQR, 6.80 to 40.78), a cytokine produced by Th17 cells, compared to those without (median, 6.38 pg/mL; IQR, 4.62 to 11.07; <italic toggle="yes">P</italic> = 0.034), while no differences were evident for any other cytokine measured. No differences were noted in cervicovaginal cytokines in women stratified by <italic toggle="yes">Candida</italic> colonization status. As coinfections may influence the relationship between <italic toggle="yes">Candida</italic> colonization and/or hypha formation and genital immunity, we performed multivariate linear regressions adjusting for BV, bacterial STIs, and HSV-2 serology. After adjusting for these confounders, women with hypha formation, but not those with <italic toggle="yes">Candida</italic> colonization only, had significantly higher levels of IL-17A (β = 0.41, <italic toggle="yes">P</italic> = 0.019), IL-17F (β = 0.54, <italic toggle="yes">P</italic> = 0.044) and IL-22 (β = 0.40, <italic toggle="yes">P</italic> = 0.0003) compared to those without, with IL-22 remaining statistically significant after adjusting for multiple comparisons (adjusted <italic toggle="yes">P</italic> = 0.039; <xref rid="fig1" ref-type="fig">Fig. 1B</xref>). These data suggest that hypha formation is associated with increased levels of Th17-produced cervicovaginal cytokines, even in the absence of symptoms.</p>
              <p><bold><italic toggle="yes">Candida</italic> colonization and cervical immune cell activation.</bold> We measured cervical cytobrush-derived T-cell frequencies and activation, with a particular emphasis on HIV target cells and those thought to be important for mucosal anti-<italic toggle="yes">Candida</italic> host defense (Fig. S1 in the supplemental material). Since cervical cytobrush samples yield too few CD3<sup>+</sup> T cells for intracellular cytokine or transcription factor staining, we used chemokine receptor expression as a proxy for T-helper cell phenotyping. We previously reported a higher frequency of cervical CD3<sup>+</sup> CD4<sup>+</sup> T cells that were CCR6+ CCR10– (considered Th17-like cells; [<xref rid="B21" ref-type="bibr">21</xref>]) compared those that were CCR6– CCR10– (considered Th1/2-enriched cells; [<xref rid="B21" ref-type="bibr">21</xref>]) in this cohort. At baseline, the frequency of activated HLA-DR+ CD4<sup>+</sup> T cells was lower among adolescents with <italic toggle="yes">Candida</italic> colonization compared to those without (<italic toggle="yes">P</italic> = 0.018), while no differences in CCR5+ CD4<sup>+</sup> HIV target cells were observed (Table S1). These adolescents also tended to have lower frequencies of activated, HIV-susceptible Th17-like cells (HLA-DR+, <italic toggle="yes">P</italic> = 0.029; CCR5+, HLA-DR+, <italic toggle="yes">P</italic> = 0.061). On the other hand, adolescents with <italic toggle="yes">Candida</italic> colonization had higher frequencies of CCR6– CCR10– CD4<sup>+</sup> T cells (<italic toggle="yes">P</italic> = 0.041), although the frequencies of activated, HIV-susceptible CCR6– CCR10– T cells were lower (CCR5+ HLA-DR +, <italic toggle="yes">P</italic> = 0.047; HLA-DR+, <italic toggle="yes">P</italic> = 0.049) than those in adolescents without <italic toggle="yes">Candida</italic> colonization (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). Similar trends were seen when comparing those with hyphae versus without hyphae on a Gram stain (Table S1 in the supplemental material). After adjusting for BV, bacterial STIs, and HSV-2 serology, women with low <italic toggle="yes">Candida</italic> colonization had significantly higher frequencies of CD4<sup>+</sup> T cells (β = 12.87, <italic toggle="yes">P</italic> = 0.027) and CCR6– CCR10– T cells (β = 10.56, <italic toggle="yes">P</italic> = 0.019) but lower frequencies of Th17-like cells (β = −10.27, <italic toggle="yes">P</italic> = 0.026) compared to women without <italic toggle="yes">Candida</italic> colonization, and similar trends seen in women with high <italic toggle="yes">Candida</italic> colonization and those who had hyphae present compared to those without (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>). These data suggest that <italic toggle="yes">Candida</italic> colonization, independent of severity and symptoms, is associated with higher frequencies of some HIV target cells (CCR6– CCR10– CD4<sup>+</sup> T cells), although overall frequencies of Th17-like cells were lower with <italic toggle="yes">Candida</italic> colonization.</p>
              <fig position="float" id="fig2">
                <label>FIG 2</label>
                <caption>
                  <p><italic toggle="yes">Candida</italic> colonization and cervical immune cells at baseline. (A) Cervical Th17 cells (CCR6+ CCR10–) and Th1/Th2-enriched cells (CCR6– CCR10–) were identified by expression of CCR6 and CCR10 on CD4<sup>+</sup> T cells. The frequencies of Th17-like and Th1/Th2-enriched cells and expression of HLA-DR and CCR5 on these cells in women with <italic toggle="yes">Candida</italic> colonization (purple) and in those without (green) was assessed at the baseline, and Wilcoxon rank-sum tests were applied to compare the frequencies between the groups. <italic toggle="yes">P</italic> values of  ≤0.05 were considered significant. (B) Multivariate linear regressions showing association between T-cell phenotypes in women with low or high <italic toggle="yes">Candida</italic> colonization compared to that in those without any colonization and in women with hyphae compared to in those without. Each association is shown as a β-coefficient and error bars represent the 95% CI. Associations shown in purple were statistically significant prior to adjusting for multiple comparisons. <italic toggle="yes">P</italic> values of ≤0.05 were considered statistically significant.</p>
                </caption>
                <graphic xlink:href="spectrum.01626-21-f002" position="float"/>
              </fig>
              <p><bold><italic toggle="yes">Candida</italic> colonization and vaginal microbiota.</bold> At baseline, BV was significantly less prevalent in adolescents with hyphae (2/12, 16.7%; Nugent 7 to 10) compared to adolescents without hyphae on Gram stains of cervicovaginal secretions (42/75, 56.0%; <italic toggle="yes">P</italic> = 0.012) (<xref rid="tab1" ref-type="table">Table 1</xref>). Consistent with this, significantly more of the participants with hyphae had a vaginal microbiota dominated by <italic toggle="yes">Lactobacillus</italic> spp., particularly <italic toggle="yes">L. iners</italic> (community state type [CST]-III; 5/12, 41.7%) and <named-content content-type="genus-species">L. crispatus</named-content> (CST-I; 4/12, 33.3%) compared to those without (15/75, 20.5% and 16/75, 21.9%, respectively; <italic toggle="yes">P</italic> = 0.030) (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). The Shannon index for the cervicovaginal microbiota, a measure of bacterial species diversity within a community, tended to be lower among women with hypha formation (median, 0.83; IQR, 0.54 to 1.46) compared to those without (median, 1.70; IQR, 0.54 to 2.17; <italic toggle="yes">P</italic> = 0.211) (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). We used DESeq2 to identify differentially abundant taxa between adolescents with <italic toggle="yes">Candida</italic> colonization or hypha formation and those without (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>). <named-content content-type="genus-species">Prevotella intermedia</named-content> and <named-content content-type="genus-species">Fusobacterium nucleatum</named-content> were significantly less abundant in vaginal specimens from adolescents with <italic toggle="yes">Candida</italic> colonization compared to in specimens from those without <italic toggle="yes">Candida</italic>. In addition to <italic toggle="yes">Prevotella</italic> and <italic toggle="yes">Fusobacterium</italic>, participants with hypha formation had lower relative abundances of taxa belonging to the <italic toggle="yes">Megasphaera</italic>, <italic toggle="yes">Mobiluncus</italic>, <italic toggle="yes">Moryella</italic>, <italic toggle="yes">Fusobacterium</italic>, <italic toggle="yes">Porphyromonas</italic>, <italic toggle="yes">Campylobacter</italic>, and <italic toggle="yes">Gardnerella</italic> genera than those without (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>, Table S2). Overall, these data suggest that there may be an association between absence of BV-associated bacteria and hypha formation in this cohort.</p>
              <fig position="float" id="fig3">
                <label>FIG 3</label>
                <caption>
                  <p>Yeast hyphae and vaginal microbiota at baseline. (A) The Shannon index, a measure of within-sample species diversity, was compared in women with yeast hyphae and in those without at baseline using a Wilcoxon rank-sum test. Prevalence of community state type (CST)-I (<named-content content-type="genus-species">Lactobacillus crispatus</named-content><italic toggle="yes">-</italic>dominated), CST-III (<italic toggle="yes">L. iners-</italic>dominated) and CST-IV (dominated by diverse, bacterial vaginosis [BV]-associated bacteria) in women with hyphae and in those without. (B) Fold-change differences in the abundances of specific vaginal bacterial taxa in women with hyphae compared to in those without. Dots to the left of 0 represent a fold-change decrease. Red dotted lines represent a 0.5-fold change difference in abundance. Only differential abundances where <italic toggle="yes">P</italic> ≤ 0.01 after adjusting for multiple comparisons were included.</p>
                </caption>
                <graphic xlink:href="spectrum.01626-21-f003" position="float"/>
              </fig>
              <p><bold>Distinguishing adolescents with yeast hyphae using cytokine, bacteria, and Th17-like cell signatures.</bold> Since we identified associations between the presence of hyphae and specific cytokines, vaginal bacteria, and cervical T-cell phenotypes, all of which may be related to each other, we integrated baseline cervicovaginal cytokines, Th17-like immune cell phenotypes, and microbial taxa at the genus level to identify the genital biomarkers that were most distinct between adolescents with hypha formation and those without. Using DIABLO (<xref rid="B30" ref-type="bibr">30</xref>), which integrates multiple data sets using supervised analysis, we found that the variables which explained the most variance between adolescents with hypha formation and those without included five cytokines (sCD40L, IL-17F, IL-22, IL-21, and IL-6), five bacterial genera (<italic toggle="yes">Lactobacillus</italic>, <italic toggle="yes">Fusobacterium</italic>, <italic toggle="yes">Moryella</italic>, <italic toggle="yes">Porphyromonas</italic>, and <italic toggle="yes">Campylobacter</italic>) and multiple highly activated Th17-like cell phenotypes (CD38+, CCR5+, CD38+ CCR5+, CD38+ HLA-DR+, CCR5+ HLA-DR+, CCR5+ CD38+ HLA-DR+) (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>). The loading weights of the selected variables suggest that differences among women with hypha formation were primarily driven by higher concentrations of IL-22 (a member of the IL-10 superfamily) but lower IL-21 and IL-6 concentrations, and lower <italic toggle="yes">Porphyromonas</italic> and <italic toggle="yes">Campylobacter</italic> abundance (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>). In agreement with our previous analyses, adolescents with hypha formation had higher levels of IL-17F, IL-22, and <italic toggle="yes">Lactobacillus</italic> but lower levels of other selected bacterial and immune cell features compared to those without hyphae (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>). <italic toggle="yes">Lactobacillus</italic> relative abundance was negatively correlated with cytokine and Th17 cell levels, while positive correlations were observed between the other selected bacteria, cytokines, and Th17 cell phenotypes (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>). After accounting for the relationship between cervicovaginal cytokines, bacteria, and Th17-like cells, the most distinguishing features between adolescents with and without hypha formation were increased levels of IL-22, decreased levels of IL-6, and decreased abundance of <named-content content-type="genus-species">Campylobacter ureolyticus</named-content>. However, these selected features poorly distinguished women with hyphae from those without, but our sample size is small (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>).</p>
              <fig position="float" id="fig4">
                <label>FIG 4</label>
                <caption>
                  <p>Distinguishing women with yeast hyphae from those without using cytokine, bacteria, and Th17 cell signatures. Multiomics feature selection model including all cytokines, bacterial taxa merged at the genus level, and Th17-like cell phenotypes which explain the highest variance when comparing women with yeast hyphae to those without. (A) Loading plot showing the contributions of the different selected biomarkers. Color indicates the group in which the variable has the maximum level of expression, using the median. (B) Circos plot showing the expression of the selected biomarkers for women without (outer green line) and those with hyphae (outer orange line), and correlations among the selected biomarkers (inner red and blue lines). Only associations above the threshold correlation cutoff, 0.3, were included. (C) Multiomics feature expression for each participant comparing the integrated cytokine, microbial, and Th17 phenotype profiles of women with hyphae (orange) and of those without (green). Cytokine (purple), bacteria (pink), and Th17-like cell (blue) clusters are shown on the top of the heatmap, and only selected features were included. Color key shows the range of correlation values.</p>
                </caption>
                <graphic xlink:href="spectrum.01626-21-f004" position="float"/>
              </fig>
              <p><bold>Hormonal contraceptive use and <italic toggle="yes">Candida</italic> colonization.</bold> Our data suggest that <italic toggle="yes">Candida</italic> colonization is associated with higher frequencies of CCR6– CCR10– CD4<sup>+</sup> T cells, a population that previously has been described as being enriched for Th1/Th2 cells (<xref rid="B21" ref-type="bibr">21</xref>), and that hypha formation is associated with significantly increased concentrations of Th17-produced cytokines. Because Th1 and Th17 cell phenotypes are both highly susceptible to HIV infection (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>), the question arises of whether the use of certain hormonal contraceptive types would result in altered incidence of <italic toggle="yes">Candida</italic> colonization or hyphae. No differences in the prevalence of <italic toggle="yes">Candida</italic> colonization by hormonal contraceptive type were observed between that at the matched baseline and that at 16 weeks post-randomization (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>). The presence of hyphae increased 3-fold in participants randomized to Net-En from 6.7% at the baseline to 20.7% at 16 weeks post-randomization (<italic toggle="yes">P</italic> = 0.116), while the prevalence in adolescents randomized to COC and NuvaRing remained unchanged (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>). No differences in the percentage of participants experiencing changes in <italic toggle="yes">Candida</italic> colonization from the baseline to week 16 were observed by hormonal contraceptive type (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>). In an intention-to-treat analysis, the incidence rate (IR) of hypha formation was 0.51 cases per person-years (95% confidence interval [CI], 0.28 to 0.94) in adolescence randomized to the Net-En arm, 0.41 cases per person-years (95% CI, 0.19 to 0.87) in the COC arm, and 0.32 cases per person-years (95% CI, 0.13 to 0.83) in the NuvaRing arm. Similarly, the proportion of adolescents in the NuvaRing arm who acquired <italic toggle="yes">Candida</italic> colonization from baseline to follow-up was almost 2-fold higher than that of those randomized to Net-En (7/12; 58.3% versus 4/13; 30.8%), with an IR for <italic toggle="yes">Candida</italic> colonization of 0.41 cases per person-years (95% CI, 0.19 to 0.87) in the Net-En arm, 0.51 cases per person-years (95% CI, 0.28 to 0.94) in the COC arm and 0.76 cases per person-years (95% CI, 0.53 to 1.10) in the NuvaRing arm. Overall, these observations suggest that NuvaRing, Net-En, and COC use had little influence on <italic toggle="yes">Candida</italic> colonization or hypha formation in this cohort with a small number of participants.</p>
              <fig position="float" id="fig5">
                <label>FIG 5</label>
                <caption>
                  <p>Hormonal contraceptive use and <italic toggle="yes">Candida</italic> colonization. (A) Prevalence of high, low, or no <italic toggle="yes">Candida</italic> colonization or hyphae at the baseline and at the 16-week follow-up in women randomized to combined oral contraceptives (COC), injectable Net-En, and NuvaRing. (B) Changes in <italic toggle="yes">Candida</italic> status of participants who were colonized with <italic toggle="yes">Candida</italic> (Pos) or <italic toggle="yes">Candida</italic>-free (Neg) from the baseline to the 16-week follow-up. Each line presents one participant and is color-coded by contraceptive randomization group.</p>
                </caption>
                <graphic xlink:href="spectrum.01626-21-f005" position="float"/>
              </fig>
              <p><bold>Effect of <italic toggle="yes">Candida</italic> persistence, clearance, and acquisition on cervicovaginal immunity.</bold> In a longitudinal analysis, there were 17 adolescents who remained free of <italic toggle="yes">Candida</italic> throughout the 16-week period (assessed by qPCR), 15 who cleared their <italic toggle="yes">Candida</italic> colonization, 16 who acquired <italic toggle="yes">Candida</italic> colonization, and 31 who remained persistently colonized.</p>
              <p>In a paired analysis, participants who remained colonized with <italic toggle="yes">Candida</italic> through time (Pos-Pos) generally experienced an increase in the concentrations of cervicovaginal cytokines produced by Th17 cells (<xref rid="fig6" ref-type="fig">Fig. 6A</xref>), and in those important for Th17 cell differentiation (<xref rid="fig6" ref-type="fig">Fig. 6B</xref>) and Th17 cell regulation (<xref rid="fig6" ref-type="fig">Fig. 6C</xref>). Concentrations of IL-6, IL-1β, TNF-α, and IL-31 (<xref rid="fig6" ref-type="fig">Fig. 6B</xref>) increased significantly from the baseline to the 16-week follow-up time point, with IL-6 remaining statistically significant after multiple-comparison adjustment (adjusted <italic toggle="yes">P</italic> = 0.0486). In contrast, participants who remained free of <italic toggle="yes">Candida</italic> throughout the 16-week study period (Neg-Neg) experienced an overall decrease in cervicovaginal cytokines, particularly sCD40L, IL-22, IL-25, and IL-31, with sCD40L remaining statistically significant after multiple-comparison adjustment (adjusted <italic toggle="yes">P</italic> = 0.0271). In contrast, no change in cervicovaginal cytokines measured was observed for participants who cleared (Pos-Neg) or acquired (Neg-Pos) <italic toggle="yes">Candida</italic> colonization between baseline and week 16 (<xref rid="fig6" ref-type="fig">Fig. 6A–C</xref>). Overall, these results suggest that persistent <italic toggle="yes">Candida</italic> colonization may be associated with a Th17 response in the FGT, involving cytokines which are thought to be important for Th17 cell differentiation (IL-1β, IL-6, TNF-α) and regulation (IL-31). Further, significant increases in frequencies of highly activated HLA-DR+ (adjusted <italic toggle="yes">P</italic> = 0.0144) and CCR5+CD38+HLA-DR+ (adjusted <italic toggle="yes">P</italic> = 0.0018) Th17-like cells (<xref rid="fig7" ref-type="fig">Fig. 7A</xref>) and highly activated HLA-DR+ (adjusted <italic toggle="yes">P</italic> = 0.0240) and CCR5+CD38+HLA-DR+ (adjusted <italic toggle="yes">P</italic> = 0.0132) CCR6-CCR10- CD4<sup>+</sup> T cells (<xref rid="fig7" ref-type="fig">Fig. 7B</xref>) were observed from baseline to the 16-week visit in participants remaining colonized with <italic toggle="yes">Candida</italic> (Pos-Pos), while again no changes in frequencies of these CD4<sup>+</sup> T cell phenotypes were observed for participants clearing or acquiring <italic toggle="yes">Candida</italic> colonization. Of the 31 participants who remained colonized with <italic toggle="yes">Candida</italic>, the majority (20/31; 64.5%) did not experience a change in colonization severity, while about a quarter (8/31; 25.8%) progressed from low to high <italic toggle="yes">Candida</italic> colonization, and few (3/31; 9.7%) moved from high to low colonization, suggesting that an increase in <italic toggle="yes">Candida</italic> colonization severity or symptoms is not required for increases in cytokine concentrations and T cell activation, but persistent colonization is sufficient. We explored associations between <italic toggle="yes">Candida</italic> clearance or acquisition and cervicovaginal cytokine concentrations (<xref rid="fig6" ref-type="fig">Fig. 6D</xref>) and T cell phenotypes (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>) in more detail using multivariate linear regressions. After adjusting for randomization arm, HSV-2 serology, BV, and bacterial STIs at baseline to account for antibiotic exposure, participants who cleared <italic toggle="yes">Candida</italic> colonization experienced a decrease in IL-17F (β= −0.90; 95% CI, −1.8 to 0; <italic toggle="yes">P</italic> = 0.05) compared to those remaining colonized, while adolescents acquiring <italic toggle="yes">Candida</italic> colonization experienced a decrease in IL-17A (β= −0.60; 95% CI, −1.12 to −0.070; <italic toggle="yes">P</italic> = 0.027) compared to those who remained <italic toggle="yes">Candida</italic>-free, neither of which remained significant after accounting for multiple comparison (<xref rid="fig6" ref-type="fig">Fig. 6D</xref>). In contrast, no significant changes were observed in immune cell frequencies or activation in multivariate linear regressions of participants who cleared or acquired <italic toggle="yes">Candida</italic> (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>). In summary, these data indicate that prolonged <italic toggle="yes">Candida</italic> colonization, even when asymptomatic, is associated with a Th17 immune response in the human FGT, while no effects of clearance or acquisitions were measurable shortly after these events.</p>
              <fig position="float" id="fig6">
                <label>FIG 6</label>
                <caption>
                  <p>Persistence, clearance, and acquisition of <italic toggle="yes">Candida</italic> colonization from baseline to 16 weeks, and cervicovaginal cytokines. Paired concentrations of cytokines produced by Th17 cells (A), those important for Th17 cell differentiation (B), and those for Th17 cell regulation (C) from baseline to 16 weeks in women who remained persistently colonized with <italic toggle="yes">Candida</italic> (Pos-Pos), those who cleared <italic toggle="yes">Candida</italic> (Pos-Neg), those who remained free of <italic toggle="yes">Candida</italic> (Neg-Neg), and those who acquired <italic toggle="yes">Candida</italic> (Neg-Pos). <italic toggle="yes">P</italic> values prior to multiple-comparison adjustment are displayed. Those remaining statistically significant after multiple-comparison adjustment are indicated by a box. (D) Multivariate linear regressions showing the association between cervicovaginal cytokines and <italic toggle="yes">Candida</italic> clearance (compared to women remaining colonized) or acquisition (compared to women remaining non-colonized). Each association is shown as a β-coefficient and error bars represent the 95% CI. Associations shown purple were statistically significant prior to adjusting for multiple comparisons. <italic toggle="yes">P</italic> values of ≤0.05 were considered statistically significant.</p>
                </caption>
                <graphic xlink:href="spectrum.01626-21-f006" position="float"/>
              </fig>
              <fig position="float" id="fig7">
                <label>FIG 7</label>
                <caption>
                  <p>Persistence, clearance, and acquisition of <italic toggle="yes">Candida</italic> colonization from baseline to 16 weeks and cervical immune cell phenotype. Paired frequencies of Th17-like (A) and CCR6– CCR10– CD4<sup>+</sup> T cells (B) from baseline to 16 weeks in women who remained persistently colonized with <italic toggle="yes">Candida</italic> (Pos-Pos), those who cleared <italic toggle="yes">Candida</italic> (Pos-Neg), those who remained free of <italic toggle="yes">Candida</italic> (Neg-Neg), and those who acquired <italic toggle="yes">Candida</italic> (Neg-Pos). <italic toggle="yes">P</italic> values prior to multiple comparison adjustment are shown. Those remaining statistically significant after multiple-comparison adjustment are indicated by a box. (C) Multivariate linear regressions showing the association between cervical T-cell phenotypes and <italic toggle="yes">Candida</italic> clearance (compared to women remaining colonized) or acquisition (compared to women remaining non-colonized). Each association is shown as a β-coefficient and error bars represent the 95% CI. <italic toggle="yes">P</italic> values of ≤0.05 were considered statistically significant.</p>
                </caption>
                <graphic xlink:href="spectrum.01626-21-f007" position="float"/>
              </fig>
            </sec>
            <sec sec-type="discussion" id="s3">
              <title>DISCUSSION</title>
              <p>Globally, adolescent girls and young women in Sub-Saharan Africa are at the highest risk for HIV infection (<xref rid="B31" ref-type="bibr">31</xref>). Cervicovaginal cytokines, T-cell phenotype and activation, and microbiota all influence sexual health and the risk of adverse outcomes in women, and may be influenced by hormonal contraceptive type. Cervical T-cell phenotype and/or activation (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>), genital tract inflammation (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B6" ref-type="bibr">6</xref>), and cervicovaginal microbiota also influence women’s risk of HIV infection (<xref rid="B6" ref-type="bibr">6</xref>), and STIs, even when asymptomatic, are associated with increased genital tract inflammation and HIV risk (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). We examined whether <italic toggle="yes">Candida</italic> colonization and/or hyphae presence is associated with cervicovaginal cytokine concentrations, T-cell phenotype and activation, and vaginal microbiota composition in adolescents not reporting any symptoms. Here, we present data suggesting that <italic toggle="yes">Candida</italic> hyphae induce IL-17- and IL-22-mediated responses in the FGT of adolescents. Both of these cytokines have been shown to be produced by a range of mucosal immune cells, including various innate lymphoid cells, such as natural killer (NK), NK T, or lymphoid tissue-inducer cells, activated CD4<sup>+</sup> and CD8<sup>+</sup> T cells, mucosa-associated invariant T cells, gamma delta T cells, and Th22 and Th17 cells (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). As expected, we found higher frequencies of CCR6– CCR10– CD4<sup>+</sup> T cells (a cell subset previously described as Th1/Th2- enriched) in adolescents with <italic toggle="yes">Candida</italic> colonization, yet lower frequencies of activated CCR6–CCR10– CD4<sup>+</sup> T cells and CCR6+ CCR10– Th17-like cells. After activation, T cells undergo a clonal expansion and differentiation, a burst of cytokine production, and finally extensive apoptosis, a phenomenon referred to as activation-induced cell death, which has also been described for both Th1 and Th17 cells (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>). It therefore seems plausible that high concentrations of IL-17 and IL-22 cause Th17-cell activation, after which the activated cells undergo cell death, which might explain the observed lower frequencies of activated CCR6–CCR10– and CCR6+ CCR10– T cells. Alternatively, the activated cells might have been more susceptible to cell death during sample collecting and processing for flow cytometry. Together, our study provides preliminary evidence that Th1/Th17-mediated immunity might be important in controlling vaginal <italic toggle="yes">Candida</italic> colonization and hypha formation in humans. Prior to this study, this had not been investigated in humans and evidence from mouse models was inconclusive (<xref rid="B11" ref-type="bibr">11</xref><xref rid="B12" ref-type="bibr">–</xref><xref rid="B15" ref-type="bibr">15</xref>).</p>
              <p>Related to this, we found that persistent <italic toggle="yes">Candida</italic> colonization over 16 weeks of follow-up, even when subclinical, led to increased frequencies of highly activated CD4<sup>+</sup> T cells, including Th17-like and CCR6– CCR10– cells, alongside increased levels of cytokines related to Th17 cell differentiation and regulation. For other FGT pathogens, such as human papillomaviruses or <named-content content-type="genus-species">C. trachomatis</named-content>, it has been suggested that persistent infection is associated with severe adverse health outcomes, while acquisition and clearance are common and have limited adverse effects (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Whether this is similarly the case for vaginal <italic toggle="yes">Candida</italic> colonization remains to be determined. Furthermore, whether persistent vaginal <italic toggle="yes">Candida</italic> colonization is associated with subsequent changes in the integrity and permeability of the vaginal barrier, as described for <italic toggle="yes">Candida</italic> colonization at the intestinal and oral mucosa (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>), which may subsequently influence HIV risk (<xref rid="B42" ref-type="bibr">42</xref>), should be investigated.</p>
              <p>Given previously reported associations between HIV risk and activated Th1/Th17 cell frequencies (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>), genital tract inflammation (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B43" ref-type="bibr">43</xref>), and vaginal epithelial barrier disruption (<xref rid="B42" ref-type="bibr">42</xref>), these findings raise the possibility that persistent <italic toggle="yes">Candida</italic> colonization could increase the risk of HIV acquisition even in the absence of symptoms. Chronic colonization with <italic toggle="yes">Candida</italic> at other mucosal surfaces has been associated with a dysregulated production of cytokines (<xref rid="B44" ref-type="bibr">44</xref>). If persistent vaginal <italic toggle="yes">Candida</italic> colonization indeed leads to increased production of Th17-related cytokines and increased frequencies of T-cell phenotypes that are susceptible to HIV infection, this may impact the risk of HIV acquisition in this key population, and screening for <italic toggle="yes">Candida</italic> colonization and subsequent treatment may mitigate some of the risk. These findings are preliminary, but important, and they require confirmation in a larger, independent cohort as well as assessment of a causal relationship between persistent <italic toggle="yes">Candida</italic> colonization and cervicovaginal immunity and/or risk of HIV acquisition, using humanized animal models or longitudinal clinical trials with HIV acquisition as an endpoint to provide conclusive evidence. Whether persistent <italic toggle="yes">Candida</italic> colonization itself, or other biological and/or behavioral factors associated with prolonged <italic toggle="yes">Candida</italic> colonization, led to the observed effects on cervicovaginal immunity needs to be investigated.</p>
              <p>The inverse association between hypha formation and BV might be surprising, as <italic toggle="yes">in vitro</italic> studies have suggested protective roles of <italic toggle="yes">Lactobacillus</italic> spp. and their metabolites against mucosal <italic toggle="yes">Candida</italic> infections (<xref rid="B45" ref-type="bibr">45</xref>). However, previous clinical studies have also described that BV diagnosed by Nugent score is associated with an absence of vaginal yeast (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). Similar to our findings, recent 16S rRNA gene sequencing-based studies have found that higher relative abundances of <italic toggle="yes">Megasphaera</italic> spp. type 1 and 2 and <named-content content-type="genus-species">Mageeibacillus indolicus</named-content> were associated with a lower risk of detecting vulvovaginal yeast (<xref rid="B48" ref-type="bibr">48</xref>), and that the odds of detecting <named-content content-type="genus-species">C. albicans</named-content> were 2-folds higher in women with <named-content content-type="genus-species">L. crispatus</named-content>-dominated vaginal CSTs compared to CSTs with lower <italic toggle="yes">Lactobacillus</italic> spp. abundances (<xref rid="B49" ref-type="bibr">49</xref>). Collectively, these data suggest that <italic toggle="yes">in vivo</italic>, vaginal <italic toggle="yes">Candida</italic> colonization is negatively associated with a vaginal microbiota composition that is characteristic of BV. The reasons for this observation need to be further investigated, but one proposed mechanistic explanation may be related to the ratio of lactic to acetic acid in the vaginal environment (<xref rid="B49" ref-type="bibr">49</xref>). BV-associated bacteria are more sensitive to lactic acid (<xref rid="B50" ref-type="bibr">50</xref>), while <named-content content-type="genus-species">C. albicans</named-content> is more sensitive to acetic acid (<xref rid="B51" ref-type="bibr">51</xref>). BV-associated bacteria produce acetic acid rather than lactic acid (<xref rid="B52" ref-type="bibr">52</xref>), which may subsequently inhibit <italic toggle="yes">Candida</italic> growth. Further supporting this theory is the fact that <named-content content-type="genus-species">L. crispatus</named-content> strains produce more lactic acid than acetic acid (<xref rid="B53" ref-type="bibr">53</xref>), which results in the inhibition of BV-associated bacteria but might have limited effects on <italic toggle="yes">Candida</italic> spp. <italic toggle="yes">in vivo</italic>.</p>
              <p>Previous observational studies have reported that certain hormonal contraceptive types are associated with increased <italic toggle="yes">Candida</italic> colonization and/or infection (<xref rid="B22" ref-type="bibr">22</xref><xref rid="B23" ref-type="bibr">–</xref><xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B29" ref-type="bibr">29</xref>). We therefore examined this within our randomized trial. Our data did not provide evidence that any contraceptive modality tested in this population of South African adolescents was associated with increased <italic toggle="yes">Candida</italic> colonization and/or hypha formation; however, our sample sizes were small. Although the prevalence of yeast hyphae as observed by Gram stain increased 3-fold from baseline to week 16 in participants randomized to Net-En, but not in COC or NuvaRing users, with the highest incidence of yeast hypha formation seen among Net-En users, this was not statistically significant. A larger, more adequately powered study might have been able to detect significant differences by contraceptive type. Furthermore, a previous study has shown that continuous, rather than intermittent, NuvaRing use is associated with symptomatic <italic toggle="yes">Candida</italic> infection (<xref rid="B29" ref-type="bibr">29</xref>). Adolescents in this cohort were given the option to either use the NuvaRing for 3 weeks followed by 7 days of non-use, or use it continuously. Many were not familiar with the NuvaRing prior to enrollment, one-third asked to change to another contraceptive method, and the self-report of perfect adherence was 78% (<xref rid="B54" ref-type="bibr">54</xref>). Therefore, some adolescents used the ring intermittently, rather than continuously, which may explain why we did not observe increased <italic toggle="yes">Candida</italic> colonization, hypha formation, and/or symptomatic VVC with NuvaRing use.</p>
              <p>The limitations of this study are that the primary outcome of the trial was not to evaluate the effect of contraceptive types on <italic toggle="yes">Candida</italic> colonization and hypha formation incidence and the study was thus not powered to detect differences, and that not all participants were contraceptive-naive prior to enrollment. The sample size of the sub-study was limited to that of the parent study. Thus, the number of adolescents with yeast hyphae was small and no cases of symptomatic VVC occurred in the parent study, which limited our ability to make confident conclusions on the relationship between yeast hyphae and microbial and immunological signatures of the FGT. However, we were able to evaluate relevant associations between asymptomatic <italic toggle="yes">Candida</italic> colonization, inflammation, immune cells, and microbiota. We acknowledge that our flow cytometry panel included surface markers only, which allowed us to detect Th1/Th2- and Th17-enriched T cells; however, these cell populations may have contained small proportions of other cell types. The numbers of cervical cells obtained using cytobrush sampling were limited, and thus measurement of intracellular expression of cytokines after stimulation was not feasible.</p>
              <p>In conclusion, this study suggests that Th17-mediated immunity is important to control <italic toggle="yes">Candida</italic> in the human female genital tract, and that persistent colonization with <italic toggle="yes">Candida</italic> may be associated with increases in Th17 cell activation and related cytokines, even when no symptoms are present. These findings have implications for adolescents at high risk of HIV and emphasize the need to evaluate the causal relationship between <italic toggle="yes">Candida</italic>, genital tract cytokines, and T-cell phenotype and function in detail in a larger, independent cohort to better inform sexual health care in Sub-Saharan African women.</p>
            </sec>
            <sec sec-type="materials|methods" id="s4">
              <title>MATERIALS AND METHODS</title>
              <sec id="s4-1">
                <title>Study cohort.</title>
                <p>Between 22 September 2015 and 30 June 2017, 130 HIV-seronegative adolescent females, aged 15 to 19 years, were recruited through the UChoose Trial, an open-label, randomized crossover study designed to evaluate the feasibility of different hormonal contraceptive options among adolescents (<xref rid="B54" ref-type="bibr">54</xref>). UChoose was approved by the Division of AIDS and the University of Cape Town (UCT) Health Science Research Ethics Committee (HREC 801/2014), was conducted in full compliance with South African Good Clinical Practice (SA-GCP), ICH76 GCP, and ICMJE guidelines, and was registered at ClinicalTrials.gov (<ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT02404038" ext-link-type="uri">https://clinicaltrials.gov/ct2/show/NCT02404038</ext-link>). Participants 18 years or older provided informed consent, while participants younger than 18 years provided assent and informed consent was obtained from a parent or legal guardian. Eligibility criteria are described in detail elsewhere (<xref rid="B54" ref-type="bibr">54</xref>), but all adolescents were either contraception-naive or on a short-term contraceptive and were willing to be assigned in a 1:1:1 ratio to one of three study arms for a 16-week period: injectable hormonal contraception (Net-En) once every 8 weeks, a combined contraceptive intravaginal ring (NuvaRing; MSD Pty LTD) to be inserted once every 28 days (and removed after 21 days of each 28-day insertion), or COC (Triphasil or Nordette). Participants returned for randomization within 40 days of the screening visit, and mucosal samples (details below) were collected at baseline and 16 weeks after hormonal contraceptive initiation for all women. Randomization was performed using random number sequence in Stata and provided to the pharmacist in sealed envelopes. All participants in the UChoose Trial were offered enrollment into this mucosal sub-study.</p>
                <p><bold>Power calculations.</bold> The sample size of the sub-study was limited to that of the parent study, where power calculations were based on the trial’s primary outcome, which was the relative acceptability of combined contraceptive vaginal ring versus other modalities based on the total score for the ORTHO Birth Control Satisfaction Assessment Tool (ORTHO BC-SAT) questionnaire at 4 months after randomization (<xref rid="B54" ref-type="bibr">54</xref>). This sub-study used samples collected as part of the parent trial with the aim of assessing associations between <italic toggle="yes">Candida</italic> colonization/hypha formation and hormonal contraceptive use, genital inflammation, cervical T-cell phenotypes, and microbiota composition.</p>
              </sec>
              <sec id="s4-2">
                <title>Sample collection.</title>
                <p>At the baseline and the follow-up at week 16 post-randomization, a rapid HIV and a pregnancy test were performed and, if positive, the participant was referred for clinical care. A detailed interviewer-assisted questionnaire assessing medical history, sexual behavior, menstrual cycle, contraceptive use, intravaginal practices, and antibiotic use was completed. Blood was collected for HSV-2 serology; vulvovaginal swabs were collected for STI, BV, yeast hyphae, pH testing (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>), 16S rRNA gene sequencing (<xref rid="B20" ref-type="bibr">20</xref>) and <italic toggle="yes">Candida</italic> qPCRs; and menstrual cups were used to collect cervicovaginal secretions for cytokine assessment by Luminex (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). A cervical cytobrush was used to collect mucosal T cells (<xref rid="B21" ref-type="bibr">21</xref>). No samples were collected during menstruation; instead, the visit was rescheduled.</p>
              </sec>
              <sec id="s4-3">
                <title>Testing for STIs, BV, and microscopic candidiasis.</title>
                <p>Serology for HSV-2 gG2 was performed using an enzyme-linked immunosorbent assay (HerpeSelect, Focus Diagnostics, USA). Vulvovaginal swabs were screened for <named-content content-type="genus-species">Chlamydia trachomatis</named-content>, <named-content content-type="genus-species">Neisseria gonorrhoeae</named-content>, <named-content content-type="genus-species">Mycoplasma genitalium</named-content>, and <named-content content-type="genus-species">Trichomonas vaginalis</named-content> by multiplex PCR (<xref rid="B20" ref-type="bibr">20</xref>). BV was determined by Nugent scoring, with 7 to 10 being considered BV-positive, 6 to 4 intermediate, and 0 to 3 BV negative. As per the 2015 Sexually Transmitted Diseases Treatment Guidelines from the Centers for Disease Control and Prevention (CDC), yeast presence was evaluated by a Gram stain of vaginal fluid which demonstrated budding yeasts, hyphae, or pseudohyphae (<xref rid="B55" ref-type="bibr">55</xref>). Vaginal pH was measured using color-fixed indicator strips (Macherey-Nagel). Laboratory-diagnosed STIs were treated with appropriate target therapy, and treatment for BV was offered to participants presenting with clinical symptoms, as per national guidelines.</p>
              </sec>
              <sec id="s4-4">
                <title>Testing for <italic toggle="yes">Candida</italic> colonization.</title>
                <p>Lateral wall vaginal swabs were treated with an enzyme cocktail consisting of mutanolysin (25kU/mL, Sigma-Aldrich), lysozyme (450 kU/mL, Sigma-Aldrich), and lysostaphin (4 kU, Sigma-Aldrich) for 1 h at 37°C. Genomic DNA was extracted using a Quick-DNA Fungal/Bacterial Miniprep Kit (Zymo Research) following the manufacturer’s protocol. Mechanical disruption was performed in a Qiagen TissueLyser LT for 5 min at 50 oz. We used a previously validated <italic toggle="yes">Candida</italic>-specific real-time PCR assay to determine the presence of <named-content content-type="genus-species">C.</named-content>
<named-content content-type="genus-species">albicans</named-content>, <named-content content-type="genus-species">C. glabrata</named-content>, <named-content content-type="genus-species">C. tropicalis</named-content>, <named-content content-type="genus-species">C. parapsilosis</named-content>, <named-content content-type="genus-species">C. guilliermondii</named-content>, <named-content content-type="genus-species">C. lusitaniae</named-content>, <named-content content-type="genus-species">C. dubliniensis</named-content>, and <named-content content-type="genus-species">C. krusei</named-content> (<xref rid="B56" ref-type="bibr">56</xref>). The ITS-2 variable region of the 28S ribosomal gene was amplified by PCR using the primers 5.8S-1F/28S-1R_Forward (5′-<named-content content-type="gene">CAA CGG ATC TCT TGG TTC TC</named-content>-3′) and 5.8S-1F/28S-1R_Reverse (5′-<named-content content-type="gene">CGG GTA GTC CTA CCT GAT TT</named-content>-3′). For each reaction, 1 μL of 5.8S-1F/28S-1R_Forward primer (100 μM), 1 μL of 5.8S-1F/28S-1R_Reverse primer (100 μM), 5 μL PowerUp SYBR Green Master Mix, 2 μL template DNA (10 to 20 ng/μL), and 1 μL molecular-grade water was used, for a final reaction volume of 10 μL. Real-time PCR was performed using a Applied Biosystems QuantStudio 7 Flex real-time PCR system with the following program: 50°C for 2 min (UDG activation) and 95°C for 2 min (<italic toggle="yes">Taq</italic> activation), followed by 40 cycles of 95°C for 15 s (denaturation) and 60°C for 1 min (annealing and extension). For each PCR run, a panel of DNA samples consisting of 5 pg, 500 fg, 100 fg, and 10 fg of <named-content content-type="genus-species">C. albicans</named-content> DNA was included, as well as a no-template control. All samples were run in duplicate. The reported lower limit of detection for this assay was 10 fg for all <italic toggle="yes">Candida</italic> species besides <named-content content-type="genus-species">C. glabrata</named-content>, for which it was 100 fg. Thus, only samples for which both reactions had a <italic toggle="yes">C<sub>T</sub></italic> value above that of the 10 fg <named-content content-type="genus-species">C. albicans</named-content> DNA were deemed to be colonized with <italic toggle="yes">Candida</italic>, while those with one value below and another above were deemed to be indeterminate and were not included in subsequent analyses. Samples with measurable <italic toggle="yes">Candida</italic> colonization were further binarized into ‘high’ and ‘low’ <italic toggle="yes">Candida</italic> colonization based on the median <italic toggle="yes">C<sub>T</sub></italic> value measured.</p>
              </sec>
              <sec id="s4-5">
                <title>Assessment of vaginal bacterial microbiota.</title>
                <p>As described in detail previously (<xref rid="B20" ref-type="bibr">20</xref>), extracted genomic DNA from lateral wall vaginal swabs was used to amplify the V4 hypervariable region of the bacterial 16S rRNA gene, using 515 F and 806 R primers. Amplicons from 96 samples were pooled in equal mass amounts and the libraries were sequenced on an Illumina MiSeq platform (300-bp paired end) with v3 chemistry. Raw sequence data for 16S rRNA gene amplicon sequences are available at <ext-link xlink:href="http://www.ebi.ac.uk/" ext-link-type="uri">http://www.ebi.ac.uk/</ext-link> under project number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB30774" ext-link-type="uri" assigning-authority="bioproject">PRJEB30774</ext-link>.</p>
              </sec>
              <sec id="s4-6">
                <title>Cytokine measurement.</title>
                <p>As described previously (<xref rid="B20" ref-type="bibr">20</xref>), cervicovaginal cytokine concentrations were measured using Luminex (Bio-Plex Pro Human Th17 cytokine panel, Bio-Rad Laboratories, Inc.), which included cytokines associated with Th17 cell differentiation (IL-1β, IL-6, TNF-α, IL-23, and IL-33), those produced by Th17 cells (IL-17A, IL-17F, IL-21, and IL-22), and those associated with Th17 cell regulation (IL-25, IL-31, IFN-γ, and soluble CD40 ligand). Data were collected using a Bio-plex Suspension Array reader, as described previously (<xref rid="B20" ref-type="bibr">20</xref>).</p>
              </sec>
              <sec id="s4-7">
                <title>Flow cytometry.</title>
                <p>Cervical cells were obtained from Digene cytobrushes, processed within 4 h, and stained immediately to measure T cell frequencies and activation by flow cytometry, as previously described (<xref rid="B21" ref-type="bibr">21</xref>). The gating strategy is shown in Fig. S1 in the supplemental material. The following panel of antibodies was included: APC-H7-CD3, BV605-CCR6, and APC-CCR5 (BD Biosciences); BV711-CD8, PE-CCR10, and Alexa-700-human leukocyte antigen (HLA) DR isotope (BioLegend); PE-Cy5.5-CD4 (Invitrogen); and PE-Cy7-cluster of differentiation 38 (CD38) (eBioscience, Inc.). LIVE-DEAD cell, Pacific-blue-CD14, and Pacific-blue-CD19 (Invitrogen) staining were performed to exclude dead cells, monocytes, and B-cells, respectively. Cells were acquired using an LSRFFortessa (BD Immunocytometry Systems). FlowJo v9.9.3 (FlowJo, LLC) was used for the data analysis.</p>
              </sec>
              <sec id="s4-8">
                <title>Data analysis.</title>
                <p>All downstream analyses were performed in RStudio. Differences in baseline characteristics were tested using Pearson’s chi-squared test or Fisher’s exact test (when the expected value was &lt;5) for count data, an unpaired Student’s <italic toggle="yes">t</italic> test for differences in mean (parametric data), and an unpaired Mann–Whitney U test for differences in medians (nonparametric data) with <italic toggle="yes">post hoc</italic> testing. Linear multivariate regression models were used to adjust for covariates, including STIs, BV and HSV-2 serology, and randomization arm, and confounders were identified using a step-up model-building strategy. Incidence rates were calculated as the number of cases with <italic toggle="yes">Candida</italic> colonization or hypha formation at the 16-week follow-up visit per person per time in years (based on the time between the baseline and the 16-week follow-up visits) within each randomization arm. The differences in IR between arms were calculated by incidence-rate ratios (IRR). Downstream data analysis of previously generated 16S rRNA gene sequencing and cytokine data (<xref rid="B20" ref-type="bibr">20</xref>), including ecological diversity metrics and fold-change differences, was performed in R (v3.6.0) using the packages (<xref rid="B57" ref-type="bibr">57</xref>), NMF (<xref rid="B58" ref-type="bibr">58</xref>), and DESeq2 (<xref rid="B59" ref-type="bibr">59</xref>). The Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO) framework, as part of the mixOmics R Bioconductor package (<xref rid="B30" ref-type="bibr">30</xref>), was used for multiomics analyses integrating the cytokine, Th17 cell phenotype, and microbiota data sets, and to select features which accounted for the highest degree of variance between women with hypha formation.</p>
              </sec>
              <sec id="s4-9">
                <title>Data availability.</title>
                <p>Raw sequence data for 16S rRNA gene amplicon sequences are available at the NCBI Sequence Read Archive under accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB30774" ext-link-type="uri" assigning-authority="bioproject">PRJEB30774</ext-link>. All other data in this study are available from the corresponding authors upon reasonable request.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="d96e330">
                <caption>
                  <title>Reviewer comments</title>
                </caption>
                <media xlink:href="reviewer-comments.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <title>ACKNOWLEDGMENTS</title>
              <p>We thank the UChoose study team and all the young women who participated in the study. We also thank the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) for making their Applied Biosystems QuantStudio 7 Flex real-time PCR system available for our use. Computations were performed using facilities provided by the University of Cape Town’s ICTS High Performance Computing team (<ext-link xlink:href="http://hpc.uct.ac.za" ext-link-type="uri">http://hpc.uct.ac.za</ext-link>).</p>
              <p>This study was supported by grants from the NIH (R01 HD083040), and Merck provided the NuvaRing.</p>
              <p>H.B.J., A.-U.H., M.G., and S.D. conceived and designed the experiments. K.G. and L.-G.B. recruited the cohort. A.-U.H., M.G., I.K., C.B., and H.G. performed wet lab experiments. A.-U.H. and H.B.J. analyzed the data. A.-U.H. and H.B.J. wrote the manuscript. J.-A.S.P. and H.B.J. acquired funding. All authors reviewed and approved the final manuscript.</p>
              <p content-type="COI-statement">The authors declare no conflict of interests.</p>
            </ack>
            <fn-group>
              <fn fn-type="supplementary-material">
                <p>Supplemental material is available online only.</p>
                <p>
                  <supplementary-material id="SuF1" position="float" content-type="local-data">
                    <object-id pub-id-type="doi">10.1128/spectrum.01626-21.1</object-id>
                    <label>SUPPLEMENTAL FILE 1</label>
                    <caption>
                      <p>Supplemental material. Download <inline-supplementary-material id="SF1" xlink:href="spectrum01626-21_supp_1_seq11.pdf" content-type="local-data">SPECTRUM01626-21_Supp_1_seq11.pdf, PDF file, 0.6 MB</inline-supplementary-material></p>
                    </caption>
                  </supplementary-material>
                </p>
              </fn>
            </fn-group>
            <ref-list>
              <title>REFERENCES</title>
              <ref id="B1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kharsany</surname><given-names>ABM</given-names></string-name>, <string-name><surname>Karim</surname><given-names>QA</given-names></string-name></person-group>. <year>2016</year>. <article-title>HIV Infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities</article-title>. <source>Open AIDS J</source><volume>10</volume>:<fpage>34</fpage>–<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1874613601610010034</pub-id>.<pub-id pub-id-type="pmid">27347270</pub-id></mixed-citation>
              </ref>
              <ref id="B2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Curtis</surname><given-names>KM</given-names></string-name>, <string-name><surname>Hannaford</surname><given-names>PC</given-names></string-name>, <string-name><surname>Rodriguez</surname><given-names>MI</given-names></string-name>, <string-name><surname>Chipato</surname><given-names>T</given-names></string-name>, <string-name><surname>Steyn</surname><given-names>PS</given-names></string-name>, <string-name><surname>Kiarie</surname><given-names>JN</given-names></string-name></person-group>. <year>2020</year>. <article-title>Hormonal contraception and HIV acquisition among women: an updated systematic review</article-title>. <source>BMJ Sex Reprod Health</source><volume>46</volume>:<fpage>8</fpage>–<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjsrh-2019-200509</pub-id>.</mixed-citation>
              </ref>
              <ref id="B3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hester</surname><given-names>RA</given-names></string-name>, <string-name><surname>Kennedy</surname><given-names>SB</given-names></string-name></person-group>. <year>2003</year>. <article-title><italic toggle="yes">Candida</italic> infection as a risk factor for HIV transmission</article-title>. <source>J Womens Health (Larchmt)</source><volume>12</volume>:<fpage>487</fpage>–<lpage>494</lpage>. doi:<pub-id pub-id-type="doi">10.1089/154099903766651612</pub-id>.<pub-id pub-id-type="pmid">12869296</pub-id></mixed-citation>
              </ref>
              <ref id="B4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Masson</surname><given-names>L</given-names></string-name>, <string-name><surname>Passmore</surname><given-names>JS</given-names></string-name>, <string-name><surname>Liebenberg</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Werner</surname><given-names>L</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>C</given-names></string-name>, <string-name><surname>Arnold</surname><given-names>KB</given-names></string-name>, <string-name><surname>Williamson</surname><given-names>C</given-names></string-name>, <string-name><surname>Little</surname><given-names>F</given-names></string-name>, <string-name><surname>Mansoor</surname><given-names>LE</given-names></string-name>, <string-name><surname>Naranbhai</surname><given-names>V</given-names></string-name>, <string-name><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name><surname>Ronacher</surname><given-names>K</given-names></string-name>, <string-name><surname>Walzl</surname><given-names>G</given-names></string-name>, <string-name><surname>Garrett</surname><given-names>NJ</given-names></string-name>, <string-name><surname>Williams</surname><given-names>BL</given-names></string-name>, <string-name><surname>Couto-Rodriguez</surname><given-names>M</given-names></string-name>, <string-name><surname>Hornig</surname><given-names>M</given-names></string-name>, <string-name><surname>Lipkin</surname><given-names>WI</given-names></string-name>, <string-name><surname>Grobler</surname><given-names>A</given-names></string-name>, <string-name><surname>Abdool Karim</surname><given-names>Q</given-names></string-name>, <string-name><surname>Abdool Karim</surname><given-names>SS</given-names></string-name></person-group>. <year>2015</year>. <article-title>Genital inflammation and the risk of HIV acquisition in women</article-title>. <source>Clin Infect Dis</source><volume>61</volume>:<fpage>260</fpage>–<lpage>269</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/civ298</pub-id>.<pub-id pub-id-type="pmid">25900168</pub-id></mixed-citation>
              </ref>
              <ref id="B5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McKinnon</surname><given-names>LR</given-names></string-name>, <string-name><surname>Kaul</surname><given-names>R</given-names></string-name></person-group>. <year>2012</year>. <article-title>Quality and quantity: mucosal CD4<sup>+</sup> T cells and HIV susceptibility</article-title>. <source>Curr Opin HIV AIDS</source><volume>7</volume>:<fpage>195</fpage>–<lpage>202</lpage>. doi:<pub-id pub-id-type="doi">10.1097/COH.0b013e3283504941</pub-id>.<pub-id pub-id-type="pmid">22314505</pub-id></mixed-citation>
              </ref>
              <ref id="B6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gosmann</surname><given-names>C</given-names></string-name>, <string-name><surname>Anahtar</surname><given-names>MN</given-names></string-name>, <string-name><surname>Handley</surname><given-names>SA</given-names></string-name>, <string-name><surname>Farcasanu</surname><given-names>M</given-names></string-name>, <string-name><surname>Abu-Ali</surname><given-names>G</given-names></string-name>, <string-name><surname>Bowman</surname><given-names>BA</given-names></string-name>, <string-name><surname>Padavattan</surname><given-names>N</given-names></string-name>, <string-name><surname>Desai</surname><given-names>C</given-names></string-name>, <string-name><surname>Droit</surname><given-names>L</given-names></string-name>, <string-name><surname>Moodley</surname><given-names>A</given-names></string-name>, <string-name><surname>Dong</surname><given-names>M</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ismail</surname><given-names>N</given-names></string-name>, <string-name><surname>Ndung'u</surname><given-names>T</given-names></string-name>, <string-name><surname>Ghebremichael</surname><given-names>MS</given-names></string-name>, <string-name><surname>Wesemann</surname><given-names>DR</given-names></string-name>, <string-name><surname>Mitchell</surname><given-names>C</given-names></string-name>, <string-name><surname>Dong</surname><given-names>KL</given-names></string-name>, <string-name><surname>Huttenhower</surname><given-names>C</given-names></string-name>, <string-name><surname>Walker</surname><given-names>BD</given-names></string-name>, <string-name><surname>Virgin</surname><given-names>HW</given-names></string-name>, <string-name><surname>Kwon</surname><given-names>DS</given-names></string-name></person-group>. <year>2017</year>. <article-title><italic toggle="yes">Lactobacillus</italic>-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women</article-title>. <source>Immunity</source><volume>46</volume>:<fpage>29</fpage>–<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2016.12.013</pub-id>.<pub-id pub-id-type="pmid">28087240</pub-id></mixed-citation>
              </ref>
              <ref id="B7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Masson</surname><given-names>L</given-names></string-name>, <string-name><surname>Mlisana</surname><given-names>K</given-names></string-name>, <string-name><surname>Little</surname><given-names>F</given-names></string-name>, <string-name><surname>Werner</surname><given-names>L</given-names></string-name>, <string-name><surname>Mkhize</surname><given-names>NN</given-names></string-name>, <string-name><surname>Ronacher</surname><given-names>K</given-names></string-name>, <string-name><surname>Gamieldien</surname><given-names>H</given-names></string-name>, <string-name><surname>Williamson</surname><given-names>C</given-names></string-name>, <string-name><surname>Mckinnon</surname><given-names>LR</given-names></string-name>, <string-name><surname>Walzl</surname><given-names>G</given-names></string-name>, <string-name><surname>Abdool Karim</surname><given-names>Q</given-names></string-name>, <string-name><surname>Abdool Karim</surname><given-names>SS</given-names></string-name>, <string-name><surname>Passmore</surname><given-names>J-AS</given-names></string-name></person-group>. <year>2014</year>. <article-title>Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study</article-title>. <source>Sex Transm Infect</source><volume>90</volume>:<fpage>580</fpage>–<lpage>588</lpage>. doi:<pub-id pub-id-type="doi">10.1136/sextrans-2014-051601</pub-id>.<pub-id pub-id-type="pmid">25107710</pub-id></mixed-citation>
              </ref>
              <ref id="B8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sobel</surname><given-names>JD</given-names></string-name></person-group>. <year>2007</year>. <article-title>Vulvovaginal candidosis</article-title>. <source>Lancet</source><volume>369</volume>:<fpage>1961</fpage>–<lpage>1971</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(07)60917-9</pub-id>.<pub-id pub-id-type="pmid">17560449</pub-id></mixed-citation>
              </ref>
              <ref id="B9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sobel</surname><given-names>JD</given-names></string-name></person-group>. <year>2016</year>. <article-title>Recurrent vulvovaginal candidiasis</article-title>. <source>Am J Obstet Gynecol</source><volume>214</volume>:<fpage>15</fpage>–<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajog.2015.06.067</pub-id>.<pub-id pub-id-type="pmid">26164695</pub-id></mixed-citation>
              </ref>
              <ref id="B10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gonçalves</surname><given-names>B</given-names></string-name>, <string-name><surname>Ferreira</surname><given-names>C</given-names></string-name>, <string-name><surname>Alves</surname><given-names>CT</given-names></string-name>, <string-name><surname>Henriques</surname><given-names>M</given-names></string-name>, <string-name><surname>Azeredo</surname><given-names>J</given-names></string-name>, <string-name><surname>Silva</surname><given-names>S</given-names></string-name></person-group>. <year>2016</year>. <article-title>Vulvovaginal candidiasis: epidemiology, microbiology and risk factors</article-title>. <source>Crit Rev Microbiol</source><volume>42</volume>:<fpage>905</fpage>–<lpage>927</lpage>. doi:<pub-id pub-id-type="doi">10.3109/1040841X.2015.1091805</pub-id>.<pub-id pub-id-type="pmid">26690853</pub-id></mixed-citation>
              </ref>
              <ref id="B11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mengesha</surname><given-names>BG</given-names></string-name>, <string-name><surname>Conti</surname><given-names>HR</given-names></string-name></person-group>. <year>2017</year>. <article-title>The role of IL-17 in protection against mucosal <italic toggle="yes">Candida</italic> infections</article-title>. <source>J Fungi (Basel)</source><volume>3</volume>:<fpage>52</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jof3040052</pub-id>.</mixed-citation>
              </ref>
              <ref id="B12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jin</surname><given-names>Y-M</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S-S</given-names></string-name>, <string-name><surname>Xu</surname><given-names>T-M</given-names></string-name>, <string-name><surname>Guo</surname><given-names>F-J</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name></person-group>. <year>2019</year>. <article-title>Impaired Th17 cell proliferation and decreased pro-inflammatory cytokine production in CXCR3/CXCR4 double-deficient mice of vulvovaginal candidiasis</article-title>. <source>J Cell Physiol</source><volume>234</volume>:<fpage>13894</fpage>–<lpage>13905</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcp.28071</pub-id>.<pub-id pub-id-type="pmid">30656691</pub-id></mixed-citation>
              </ref>
              <ref id="B13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yano</surname><given-names>J</given-names></string-name>, <string-name><surname>Kolls</surname><given-names>JK</given-names></string-name>, <string-name><surname>Happel</surname><given-names>KI</given-names></string-name>, <string-name><surname>Wormley</surname><given-names>F</given-names></string-name>, <string-name><surname>Wozniak</surname><given-names>KL</given-names></string-name>, <string-name><surname>Fidel</surname><given-names>PLJ</given-names></string-name></person-group>. <year>2012</year>. <article-title>The acute neutrophil response mediated by S100 alarmins during vaginal <italic toggle="yes">Candida</italic> infections is independent of the Th17-pathway</article-title>. <source>PLoS One</source><volume>7</volume>:<elocation-id>e46311</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0046311</pub-id>.<pub-id pub-id-type="pmid">23050010</pub-id></mixed-citation>
              </ref>
              <ref id="B14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peters</surname><given-names>BM</given-names></string-name>, <string-name><surname>Coleman</surname><given-names>BM</given-names></string-name>, <string-name><surname>Willems</surname><given-names>HME</given-names></string-name>, <string-name><surname>Barker</surname><given-names>KS</given-names></string-name>, <string-name><surname>Aggor</surname><given-names>FEY</given-names></string-name>, <string-name><surname>Cipolla</surname><given-names>E</given-names></string-name>, <string-name><surname>Verma</surname><given-names>AH</given-names></string-name>, <string-name><surname>Bishu</surname><given-names>S</given-names></string-name>, <string-name><surname>Huppler</surname><given-names>AH</given-names></string-name>, <string-name><surname>Bruno</surname><given-names>VM</given-names></string-name>, <string-name><surname>Gaffen</surname><given-names>SL</given-names></string-name></person-group>. <year>2020</year>. <article-title>The interleukin (IL) 17R/IL-22R signaling axis is dispensable for vulvovaginal candidiasis regardless of estrogen Status</article-title>. <source>J Infect Dis</source><volume>221</volume>:<fpage>1554</fpage>–<lpage>1563</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiz649</pub-id>.<pub-id pub-id-type="pmid">31805183</pub-id></mixed-citation>
              </ref>
              <ref id="B15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ibrahim</surname><given-names>AS</given-names></string-name>, <string-name><surname>Luo</surname><given-names>G</given-names></string-name>, <string-name><surname>Gebremariam</surname><given-names>T</given-names></string-name>, <string-name><surname>Lee</surname><given-names>H</given-names></string-name>, <string-name><surname>Schmidt</surname><given-names>CS</given-names></string-name>, <string-name><surname>Hennessey</surname><given-names>JPJ</given-names></string-name>, <string-name><surname>French</surname><given-names>SW</given-names></string-name>, <string-name><surname>Yeaman</surname><given-names>MR</given-names></string-name>, <string-name><surname>Filler</surname><given-names>SG</given-names></string-name>, <string-name><surname>Edwards</surname><given-names>JEJ</given-names></string-name></person-group>. <year>2013</year>. <article-title>NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response</article-title>. <source>Vaccine</source><volume>31</volume>:<fpage>5549</fpage>–<lpage>5556</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2013.09.016</pub-id>.<pub-id pub-id-type="pmid">24063977</pub-id></mixed-citation>
              </ref>
              <ref id="B16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jin</surname><given-names>W</given-names></string-name>, <string-name><surname>Dong</surname><given-names>C</given-names></string-name></person-group>. <year>2013</year>. <article-title>IL-17 cytokines in immunity and inflammation</article-title>. <source>Emerg Microbes Infect</source><volume>2</volume>:<elocation-id>e60</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/emi.2013.58</pub-id>.<pub-id pub-id-type="pmid">26038490</pub-id></mixed-citation>
              </ref>
              <ref id="B17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>HL</given-names></string-name>, <string-name><surname>Jang</surname><given-names>JW</given-names></string-name>, <string-name><surname>Lee</surname><given-names>SW</given-names></string-name>, <string-name><surname>Yoo</surname><given-names>SH</given-names></string-name>, <string-name><surname>Kwon</surname><given-names>JH</given-names></string-name>, <string-name><surname>Nam</surname><given-names>SW</given-names></string-name>, <string-name><surname>Bae</surname><given-names>SH</given-names></string-name>, <string-name><surname>Choi</surname><given-names>JY</given-names></string-name>, <string-name><surname>Han</surname><given-names>NI</given-names></string-name>, <string-name><surname>Yoon</surname><given-names>SK</given-names></string-name></person-group>. <year>2019</year>. <article-title>Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization</article-title>. <source>Sci Rep</source><volume>9</volume>:<fpage>3260</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-40078-8</pub-id>.<pub-id pub-id-type="pmid">30824840</pub-id></mixed-citation>
              </ref>
              <ref id="B18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>H</given-names></string-name>, <string-name><surname>Kim</surname><given-names>D</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Kiselinova</surname><given-names>M</given-names></string-name>, <string-name><surname>Ouyang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Vandekerckhove</surname><given-names>L</given-names></string-name>, <string-name><surname>Shang</surname><given-names>H</given-names></string-name>, <string-name><surname>Rosenberg</surname><given-names>ES</given-names></string-name>, <string-name><surname>Yu</surname><given-names>XG</given-names></string-name>, <string-name><surname>Lichterfeld</surname><given-names>M</given-names></string-name></person-group>. <year>2015</year>. <article-title>Th1/17 polarization of CD4 T cells supports HIV-1 persistence during antiretroviral therapy</article-title>. <source>J Virol</source><volume>89</volume>:<fpage>11284</fpage>–<lpage>11293</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01595-15</pub-id>.<pub-id pub-id-type="pmid">26339043</pub-id></mixed-citation>
              </ref>
              <ref id="B19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alvarez</surname><given-names>Y</given-names></string-name>, <string-name><surname>Tuen</surname><given-names>M</given-names></string-name>, <string-name><surname>Shen</surname><given-names>G</given-names></string-name>, <string-name><surname>Nawaz</surname><given-names>F</given-names></string-name>, <string-name><surname>Arthos</surname><given-names>J</given-names></string-name>, <string-name><surname>Wolff</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Poles</surname><given-names>MA</given-names></string-name>, <string-name><surname>Hioe</surname><given-names>CE</given-names></string-name></person-group>. <year>2013</year>. <article-title>Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands</article-title>. <source>J Virol</source><volume>87</volume>:<fpage>10843</fpage>–<lpage>10854</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JVI.01838-13</pub-id>.<pub-id pub-id-type="pmid">23903844</pub-id></mixed-citation>
              </ref>
              <ref id="B20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balle</surname><given-names>C</given-names></string-name>, <string-name><surname>Konstantinus</surname><given-names>IN</given-names></string-name>, <string-name><surname>Jaumdally</surname><given-names>SZ</given-names></string-name>, <string-name><surname>Havyarimana</surname><given-names>E</given-names></string-name>, <string-name><surname>Lennard</surname><given-names>K</given-names></string-name>, <string-name><surname>Esra</surname><given-names>R</given-names></string-name>, <string-name><surname>Barnabas</surname><given-names>SL</given-names></string-name>, <string-name><surname>Happel</surname><given-names>A-U</given-names></string-name>, <string-name><surname>Moodie</surname><given-names>Z</given-names></string-name>, <string-name><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name><surname>Pidwell</surname><given-names>T</given-names></string-name>, <string-name><surname>Karaoz</surname><given-names>U</given-names></string-name>, <string-name><surname>Brodie</surname><given-names>E</given-names></string-name>, <string-name><surname>Maseko</surname><given-names>V</given-names></string-name>, <string-name><surname>Gamieldien</surname><given-names>H</given-names></string-name>, <string-name><surname>Bosinger</surname><given-names>SE</given-names></string-name>, <string-name><surname>Myer</surname><given-names>L</given-names></string-name>, <string-name><surname>Bekker</surname><given-names>L-G</given-names></string-name>, <string-name><surname>Passmore</surname><given-names>J-AS</given-names></string-name>, <string-name><surname>Jaspan</surname><given-names>HB</given-names></string-name></person-group>. <year>2020</year>. <article-title>Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial</article-title>. <source>Nat Commun</source><volume>11</volume>:<fpage>5578</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-020-19382-9</pub-id>.<pub-id pub-id-type="pmid">33149114</pub-id></mixed-citation>
              </ref>
              <ref id="B21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Konstantinus</surname><given-names>IN</given-names></string-name>, <string-name><surname>Balle</surname><given-names>C</given-names></string-name>, <string-name><surname>Jaumdally</surname><given-names>SZ</given-names></string-name>, <string-name><surname>Galmieldien</surname><given-names>H</given-names></string-name>, <string-name><surname>Pidwell</surname><given-names>T</given-names></string-name>, <string-name><surname>Masson</surname><given-names>L</given-names></string-name>, <string-name><surname>Tanko</surname><given-names>RF</given-names></string-name>, <string-name><surname>Happel</surname><given-names>A-U</given-names></string-name>, <string-name><surname>Sinkala</surname><given-names>M</given-names></string-name>, <string-name><surname>Myer</surname><given-names>L</given-names></string-name>, <string-name><surname>Bosinger</surname><given-names>SE</given-names></string-name>, <string-name><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name><surname>Bekker</surname><given-names>L-G</given-names></string-name>, <string-name><surname>Jaspan</surname><given-names>HB</given-names></string-name>, <string-name><surname>Passmore</surname><given-names>J-AS</given-names></string-name></person-group>. <year>2019</year>. <article-title>Impact of hormonal contraceptives on cervical T-helper 17 phenotype and function in adolescents: results from a randomized, crossover study comparing long-acting injectable norethisterone oenanthate (NET-EN), combined oral contraceptive pills, and combined contraceptive vaginal rings</article-title>. <source>Clin Infect Dis</source><volume>71</volume>:<fpage>e76</fpage>–<lpage>e87</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/ciz1063</pub-id>.</mixed-citation>
              </ref>
              <ref id="B22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Egbe</surname><given-names>CA</given-names></string-name>, <string-name><surname>Onwufor</surname><given-names>UC</given-names></string-name>, <string-name><surname>Omoregie</surname><given-names>R</given-names></string-name>, <string-name><surname>Enabulele</surname><given-names>OI</given-names></string-name></person-group>. <year>2011</year>. <article-title>Female reproductive tract infections among vaginal contraceptive users in Benin City, Nigeria</article-title>. <source>Genomic Med Biomarkers, Heal Sci</source><volume>3</volume>:<fpage>49</fpage>–<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2211-4254(11)60007-1</pub-id>.</mixed-citation>
              </ref>
              <ref id="B23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yusuf</surname><given-names>M</given-names></string-name>, <string-name><surname>Chowdhury</surname><given-names>MA</given-names></string-name>, <string-name><surname>Sattar</surname><given-names>AN</given-names></string-name>, <string-name><surname>Rahman</surname><given-names>MM</given-names></string-name></person-group>. <year>2016</year>. <article-title>Evaluation of the effect of contraceptives on prevalence of <italic toggle="yes">Candida</italic> species on vaginal candidiasis in Dhaka, Bangladesh</article-title>. <source>Bangladesh J Med Microbiol</source><volume>1</volume>:<fpage>61</fpage>–<lpage>64</lpage>. doi:<pub-id pub-id-type="doi">10.3329/bjmm.v1i2.21511</pub-id>.</mixed-citation>
              </ref>
              <ref id="B24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Apalata</surname><given-names>T</given-names></string-name>, <string-name><surname>Longo-Mbenza</surname><given-names>B</given-names></string-name>, <string-name><surname>Sturm</surname><given-names>A</given-names></string-name>, <string-name><surname>Carr</surname><given-names>W</given-names></string-name>, <string-name><surname>Moodley</surname><given-names>P</given-names></string-name></person-group>. <year>2014</year>. <article-title>Factors associated with symptomatic vulvovaginal candidiasis: a study among women attending a primary healthcare clinic in Kwazulu-Natal, South Africa</article-title>. <source>Ann Med Health Sci Res</source><volume>4</volume>:<fpage>410</fpage>–<lpage>416</lpage>. doi:<pub-id pub-id-type="doi">10.4103/2141-9248.133470</pub-id>.<pub-id pub-id-type="pmid">24971218</pub-id></mixed-citation>
              </ref>
              <ref id="B25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jacob</surname><given-names>L</given-names></string-name>, <string-name><surname>John</surname><given-names>M</given-names></string-name>, <string-name><surname>Kalder</surname><given-names>M</given-names></string-name>, <string-name><surname>Kostev</surname><given-names>K</given-names></string-name></person-group>. <year>2018</year>. <article-title>Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: a retrospective study of 954,186 patients</article-title>. <source>Curr Med Mycol</source><volume>4</volume>:<fpage>6</fpage>–<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.18502/cmm.4.1.27</pub-id>.<pub-id pub-id-type="pmid">30186987</pub-id></mixed-citation>
              </ref>
              <ref id="B26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lal</surname><given-names>P</given-names></string-name>, <string-name><surname>Agarwal</surname><given-names>V</given-names></string-name>, <string-name><surname>Pruthi</surname><given-names>P</given-names></string-name>, <string-name><surname>Pereira</surname><given-names>BMJ</given-names></string-name>, <string-name><surname>Kural</surname><given-names>MR</given-names></string-name>, <string-name><surname>Pruthi</surname><given-names>V</given-names></string-name></person-group>. <year>2008</year>. <article-title>Biofilm formation by <italic toggle="yes">Candida albicans</italic> isolated from intrauterine devices</article-title>. <source>Indian J Microbiol</source><volume>48</volume>:<fpage>438</fpage>–<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12088-008-0054-x</pub-id>.<pub-id pub-id-type="pmid">23100744</pub-id></mixed-citation>
              </ref>
              <ref id="B27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guzel</surname><given-names>AB</given-names></string-name>, <string-name><surname>Ilkit</surname><given-names>M</given-names></string-name>, <string-name><surname>Akar</surname><given-names>T</given-names></string-name>, <string-name><surname>Burgut</surname><given-names>R</given-names></string-name>, <string-name><surname>Demir</surname><given-names>SC</given-names></string-name></person-group>. <year>2011</year>. <article-title>Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID <italic toggle="yes">Candida</italic> agar versus CHROMagar <italic toggle="yes">Candida</italic> for recovery and presumptive identification of vaginal yeast species</article-title>. <source>Med Mycol</source><volume>49</volume>:<fpage>16</fpage>–<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.3109/13693786.2010.497972</pub-id>.<pub-id pub-id-type="pmid">20608776</pub-id></mixed-citation>
              </ref>
              <ref id="B28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Camacho</surname><given-names>DP</given-names></string-name>, <string-name><surname>Consolaro</surname><given-names>MEL</given-names></string-name>, <string-name><surname>Patussi</surname><given-names>EV</given-names></string-name>, <string-name><surname>Donatti</surname><given-names>L</given-names></string-name>, <string-name><surname>Gasparetto</surname><given-names>A</given-names></string-name>, <string-name><surname>Svidzinski</surname><given-names>TIE</given-names></string-name></person-group>. <year>2007</year>. <article-title>Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR)</article-title>. <source>Contraception</source><volume>76</volume>:<fpage>439</fpage>–<lpage>443</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.contraception.2007.07.012</pub-id>.<pub-id pub-id-type="pmid">18061701</pub-id></mixed-citation>
              </ref>
              <ref id="B29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kestelyn</surname><given-names>E</given-names></string-name>, <string-name><surname>Agaba</surname><given-names>S</given-names></string-name>, <string-name><surname>Van Nuil</surname><given-names>JI</given-names></string-name>, <string-name><surname>Uwineza</surname><given-names>M</given-names></string-name>, <string-name><surname>Umulisa</surname><given-names>MM</given-names></string-name>, <string-name><surname>Mwambarangwe</surname><given-names>L</given-names></string-name>, <string-name><surname>Ndagijimana</surname><given-names>JC</given-names></string-name>, <string-name><surname>De Baetselier</surname><given-names>I</given-names></string-name>, <string-name><surname>Buyze</surname><given-names>J</given-names></string-name>, <string-name><surname>Delvaux</surname><given-names>T</given-names></string-name>, <string-name><surname>Crucitti</surname><given-names>T</given-names></string-name>, <string-name><surname>Jespers</surname><given-names>V</given-names></string-name>, <string-name><surname>van de Wijgert</surname><given-names>JHHM</given-names></string-name>, <string-name><surname>Group For The</surname><given-names>RPS</given-names></string-name>, <collab>Ring Plus Study Group</collab></person-group>. <year>2018</year>. <article-title>A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: safety of intermittent and continuous use</article-title>. <source>PLoS One</source><volume>13</volume>:<elocation-id>e0197572</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0197572</pub-id>.<pub-id pub-id-type="pmid">29856848</pub-id></mixed-citation>
              </ref>
              <ref id="B30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname><given-names>A</given-names></string-name>, <string-name><surname>Shannon</surname><given-names>CP</given-names></string-name>, <string-name><surname>Gautier</surname><given-names>B</given-names></string-name>, <string-name><surname>Rohart</surname><given-names>F</given-names></string-name>, <string-name><surname>Vacher</surname><given-names>M</given-names></string-name>, <string-name><surname>Tebbutt</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Lê Cao</surname><given-names>K-A</given-names></string-name></person-group>. <year>2019</year>. <article-title>DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays</article-title>. <source>Bioinformatics</source><volume>35</volume>:<fpage>3055</fpage>–<lpage>3062</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/bty1054</pub-id>.<pub-id pub-id-type="pmid">30657866</pub-id></mixed-citation>
              </ref>
              <ref id="B31">
                <label>31</label>
                <mixed-citation publication-type="book"><collab>WHO</collab>. <year>2018</year>. <source>Global AIDS Update.</source><publisher-name>WHO</publisher-name>, <publisher-loc>Geneva, Switzerland</publisher-loc>.</mixed-citation>
              </ref>
              <ref id="B32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arnold</surname><given-names>KB</given-names></string-name>, <string-name><surname>Burgener</surname><given-names>A</given-names></string-name>, <string-name><surname>Birse</surname><given-names>K</given-names></string-name>, <string-name><surname>Romas</surname><given-names>L</given-names></string-name>, <string-name><surname>Dunphy</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Shahabi</surname><given-names>K</given-names></string-name>, <string-name><surname>Abou</surname><given-names>M</given-names></string-name>, <string-name><surname>Westmacott</surname><given-names>GR</given-names></string-name>, <string-name><surname>McCorrister</surname><given-names>S</given-names></string-name>, <string-name><surname>Kwatampora</surname><given-names>J</given-names></string-name>, <string-name><surname>Nyanga</surname><given-names>B</given-names></string-name>, <string-name><surname>Kimani</surname><given-names>J</given-names></string-name>, <string-name><surname>Masson</surname><given-names>L</given-names></string-name>, <string-name><surname>Liebenberg</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Abdool Karim</surname><given-names>SS</given-names></string-name>, <string-name><surname>Passmore</surname><given-names>J-AS</given-names></string-name>, <string-name><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name><surname>Kaul</surname><given-names>R</given-names></string-name>, <string-name><surname>McKinnon</surname><given-names>LR</given-names></string-name></person-group>. <year>2016</year>. <article-title>Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells</article-title>. <source>Mucosal Immunol</source><volume>9</volume>:<fpage>194</fpage>–<lpage>205</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mi.2015.51</pub-id>.<pub-id pub-id-type="pmid">26104913</pub-id></mixed-citation>
              </ref>
              <ref id="B33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Masson</surname><given-names>L</given-names></string-name>, <string-name><surname>Arnold</surname><given-names>KB</given-names></string-name>, <string-name><surname>Little</surname><given-names>F</given-names></string-name>, <string-name><surname>Mlisana</surname><given-names>K</given-names></string-name>, <string-name><surname>Lewis</surname><given-names>DA</given-names></string-name>, <string-name><surname>Mkhize</surname><given-names>N</given-names></string-name>, <string-name><surname>Gamieldien</surname><given-names>H</given-names></string-name>, <string-name><surname>Ngcapu</surname><given-names>S</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>L</given-names></string-name>, <string-name><surname>Lauffenburger</surname><given-names>DA</given-names></string-name>, <string-name><surname>Abdool Karim</surname><given-names>Q</given-names></string-name>, <string-name><surname>Abdool Karim</surname><given-names>SS</given-names></string-name>, <string-name><surname>Passmore</surname><given-names>JAS</given-names></string-name></person-group>. <year>2016</year>. <article-title>Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection</article-title>. <source>Sex Transm Infect</source><volume>92</volume>:<fpage>186</fpage>–<lpage>193</lpage>. doi:<pub-id pub-id-type="doi">10.1136/sextrans-2015-052072</pub-id>.<pub-id pub-id-type="pmid">26511781</pub-id></mixed-citation>
              </ref>
              <ref id="B34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gibbs</surname><given-names>A</given-names></string-name>, <string-name><surname>Leeansyah</surname><given-names>E</given-names></string-name>, <string-name><surname>Introini</surname><given-names>A</given-names></string-name>, <string-name><surname>Paquin-Proulx</surname><given-names>D</given-names></string-name>, <string-name><surname>Hasselrot</surname><given-names>K</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <string-name><surname>Broliden</surname><given-names>K</given-names></string-name>, <string-name><surname>Sandberg</surname><given-names>JK</given-names></string-name>, <string-name><surname>Tjernlund</surname><given-names>A</given-names></string-name></person-group>. <year>2017</year>. <article-title>MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation</article-title>. <source>Mucosal Immunol</source><volume>10</volume>:<fpage>35</fpage>–<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mi.2016.30</pub-id>.<pub-id pub-id-type="pmid">27049062</pub-id></mixed-citation>
              </ref>
              <ref id="B35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valeri</surname><given-names>M</given-names></string-name>, <string-name><surname>Raffatellu</surname><given-names>M</given-names></string-name></person-group>. <year>2016</year>. <article-title>Cytokines IL-17 and IL-22 in the host response to infection</article-title>. <source>Pathog Dis</source><volume>74</volume>:<fpage>ftw111</fpage>. doi:<pub-id pub-id-type="doi">10.1093/femspd/ftw111</pub-id>.<pub-id pub-id-type="pmid">27915228</pub-id></mixed-citation>
              </ref>
              <ref id="B36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname><given-names>G</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>AI</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Y</given-names></string-name></person-group>. <year>2008</year>. <article-title>Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma</article-title>. <source>J Immunol</source><volume>181</volume>:<fpage>190</fpage>–<lpage>196</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.181.1.190</pub-id>.<pub-id pub-id-type="pmid">18566384</pub-id></mixed-citation>
              </ref>
              <ref id="B37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname><given-names>S</given-names></string-name>, <string-name><surname>Ellis</surname><given-names>JS</given-names></string-name>, <string-name><surname>Sharav</surname><given-names>T</given-names></string-name>, <string-name><surname>Braley-Mullen</surname><given-names>H</given-names></string-name></person-group>. <year>2010</year>. <article-title>Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis</article-title>. <source>J Leukoc Biol</source><volume>87</volume>:<fpage>1019</fpage>–<lpage>1028</lpage>. doi:<pub-id pub-id-type="doi">10.1189/jlb.0509352</pub-id>.<pub-id pub-id-type="pmid">20179154</pub-id></mixed-citation>
              </ref>
              <ref id="B38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gravitt</surname><given-names>PE</given-names></string-name>, <string-name><surname>Winer</surname><given-names>RL</given-names></string-name></person-group>. <year>2017</year>. <article-title>Natural history of HPV infection across the lifespan: role of viral latency</article-title>. <source>Viruses</source><volume>9</volume>:<fpage>267</fpage>. doi:<pub-id pub-id-type="doi">10.3390/v9100267</pub-id>.</mixed-citation>
              </ref>
              <ref id="B39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Witkin</surname><given-names>SS</given-names></string-name>, <string-name><surname>Minis</surname><given-names>E</given-names></string-name>, <string-name><surname>Athanasiou</surname><given-names>A</given-names></string-name>, <string-name><surname>Leizer</surname><given-names>J</given-names></string-name>, <string-name><surname>Linhares</surname><given-names>IM</given-names></string-name></person-group>. <year>2017</year>. <article-title><italic toggle="yes">Chlamydia trachomatis</italic>: the persistent pathogen</article-title>. <source>Clin Vaccine Immunol</source><volume>24</volume>:<elocation-id>e00203-17</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/CVI.00203-17</pub-id>.<pub-id pub-id-type="pmid">28835360</pub-id></mixed-citation>
              </ref>
              <ref id="B40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tong</surname><given-names>Y</given-names></string-name>, <string-name><surname>Tang</surname><given-names>J</given-names></string-name></person-group>. <year>2017</year>. <article-title><italic toggle="yes">Candida albicans</italic> infection and intestinal immunity</article-title>. <source>Microbiol Res</source><volume>198</volume>:<fpage>27</fpage>–<lpage>35</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micres.2017.02.002</pub-id>.<pub-id pub-id-type="pmid">28285659</pub-id></mixed-citation>
              </ref>
              <ref id="B41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Villar</surname><given-names>CC</given-names></string-name>, <string-name><surname>Kashleva</surname><given-names>H</given-names></string-name>, <string-name><surname>Nobile</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Mitchell</surname><given-names>AP</given-names></string-name>, <string-name><surname>Dongari-Bagtzoglou</surname><given-names>A</given-names></string-name></person-group>. <year>2007</year>. <article-title>Mucosal tissue invasion by <italic toggle="yes">Candida albicans</italic> is associated with E-Cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p</article-title>. <source>Infect Immun</source><volume>75</volume>:<fpage>2126</fpage>–<lpage>2135</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.00054-07</pub-id>.<pub-id pub-id-type="pmid">17339363</pub-id></mixed-citation>
              </ref>
              <ref id="B42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abbai</surname><given-names>NS</given-names></string-name>, <string-name><surname>Wand</surname><given-names>H</given-names></string-name>, <string-name><surname>Ramjee</surname><given-names>G</given-names></string-name></person-group>. <year>2016</year>. <article-title>Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban</article-title>. <source>BMC Womens Health</source><volume>16</volume>:<fpage>19</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12905-016-0295-5</pub-id>.<pub-id pub-id-type="pmid">26992693</pub-id></mixed-citation>
              </ref>
              <ref id="B43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Passmore</surname><given-names>J-AS</given-names></string-name>, <string-name><surname>Jaspan</surname><given-names>HB</given-names></string-name>, <string-name><surname>Masson</surname><given-names>L</given-names></string-name></person-group>. <year>2016</year>. <article-title>Genital inflammation, immune activation and risk of sexual HIV acquisition</article-title>. <source>Curr Opin HIV AIDS</source><volume>11</volume>:<fpage>156</fpage>–<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1097/COH.0000000000000232</pub-id>.<pub-id pub-id-type="pmid">26628324</pub-id></mixed-citation>
              </ref>
              <ref id="B44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lilic</surname><given-names>D</given-names></string-name>, <string-name><surname>Gravenor</surname><given-names>I</given-names></string-name>, <string-name><surname>Robson</surname><given-names>N</given-names></string-name>, <string-name><surname>Lammas</surname><given-names>DA</given-names></string-name>, <string-name><surname>Drysdale</surname><given-names>P</given-names></string-name>, <string-name><surname>Calvert</surname><given-names>JE</given-names></string-name>, <string-name><surname>Cant</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Abinun</surname><given-names>M</given-names></string-name></person-group>. <year>2003</year>. <article-title>Deregulated production of protective cytokines in response to <italic toggle="yes">Candida albicans</italic> infection in patients with chronic mucocutaneous candidiasis</article-title>. <source>Infect Immun</source><volume>71</volume>:<fpage>5690</fpage>–<lpage>5699</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.71.10.5690-5699.2003</pub-id>.<pub-id pub-id-type="pmid">14500490</pub-id></mixed-citation>
              </ref>
              <ref id="B45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jang</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Lee</surname><given-names>K</given-names></string-name>, <string-name><surname>Kwon</surname><given-names>B</given-names></string-name>, <string-name><surname>You</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Ko</surname><given-names>G</given-names></string-name></person-group>. <year>2019</year>. <article-title>Vaginal lactobacilli inhibit growth and hyphae formation of <italic toggle="yes">Candida albicans</italic></article-title>. <source>Sci Rep</source><volume>9</volume>:<fpage>8121</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-44579-4</pub-id>.<pub-id pub-id-type="pmid">31148560</pub-id></mixed-citation>
              </ref>
              <ref id="B46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McClelland</surname><given-names>RS</given-names></string-name>, <string-name><surname>Richardson</surname><given-names>BA</given-names></string-name>, <string-name><surname>Hassan</surname><given-names>WM</given-names></string-name>, <string-name><surname>Graham</surname><given-names>SM</given-names></string-name>, <string-name><surname>Kiarie</surname><given-names>J</given-names></string-name>, <string-name><surname>Baeten</surname><given-names>JM</given-names></string-name>, <string-name><surname>Mandaliya</surname><given-names>K</given-names></string-name>, <string-name><surname>Jaoko</surname><given-names>W</given-names></string-name>, <string-name><surname>Ndinya-Achola</surname><given-names>JO</given-names></string-name>, <string-name><surname>Holmes</surname><given-names>KK</given-names></string-name></person-group>. <year>2009</year>. <article-title>Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis</article-title>. <source>J Infect Dis</source><volume>199</volume>:<fpage>1883</fpage>–<lpage>1890</lpage>. doi:<pub-id pub-id-type="doi">10.1086/599213</pub-id>.<pub-id pub-id-type="pmid">19456235</pub-id></mixed-citation>
              </ref>
              <ref id="B47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moodley</surname><given-names>P</given-names></string-name>, <string-name><surname>Connolly</surname><given-names>C</given-names></string-name>, <string-name><surname>Sturm</surname><given-names>AW</given-names></string-name></person-group>. <year>2002</year>. <article-title>Interrelationships among Human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts</article-title>. <source>J Infect Dis</source><volume>185</volume>:<fpage>69</fpage>–<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1086/338027</pub-id>.<pub-id pub-id-type="pmid">11756983</pub-id></mixed-citation>
              </ref>
              <ref id="B48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eastment</surname><given-names>MC</given-names></string-name>, <string-name><surname>Balkus</surname><given-names>JE</given-names></string-name>, <string-name><surname>Richardson</surname><given-names>BA</given-names></string-name>, <string-name><surname>Srinivasan</surname><given-names>S</given-names></string-name>, <string-name><surname>Kimani</surname><given-names>J</given-names></string-name>, <string-name><surname>Anzala</surname><given-names>O</given-names></string-name>, <string-name><surname>Schwebke</surname><given-names>J</given-names></string-name>, <string-name><surname>Fiedler</surname><given-names>TL</given-names></string-name>, <string-name><surname>Fredricks</surname><given-names>DN</given-names></string-name>, <string-name><surname>McClelland</surname><given-names>RS</given-names></string-name></person-group>. <year>2021</year>. <article-title>Association between vaginal bacterial microbiota and vaginal yeast colonization</article-title>. <source>J Infect Dis</source><volume>223</volume>:<fpage>914</fpage>–<lpage>923</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiaa459</pub-id>.<pub-id pub-id-type="pmid">32726445</pub-id></mixed-citation>
              </ref>
              <ref id="B49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brown</surname><given-names>SE</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>JA</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>CK</given-names></string-name>, <string-name><surname>O’hanlon</surname><given-names>DE</given-names></string-name>, <string-name><surname>Bradford</surname><given-names>LL</given-names></string-name>, <string-name><surname>He</surname><given-names>X</given-names></string-name>, <string-name><surname>Mark</surname><given-names>KS</given-names></string-name>, <string-name><surname>Bruno</surname><given-names>VM</given-names></string-name>, <string-name><surname>Ravel</surname><given-names>J</given-names></string-name>, <string-name><surname>Brotman</surname><given-names>RM</given-names></string-name></person-group>. <year>2019</year>. <article-title>The vaginal microbiota and behavioral factors associated with genital <italic toggle="yes">Candida albicans</italic> detection in reproductive-age women</article-title>. <source>Sex Transm Dis</source><volume>46</volume>:<fpage>753</fpage>–<lpage>758</lpage>. doi:<pub-id pub-id-type="doi">10.1097/OLQ.0000000000001066</pub-id>.<pub-id pub-id-type="pmid">31517769</pub-id></mixed-citation>
              </ref>
              <ref id="B50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Hanlon</surname><given-names>DEO</given-names></string-name>, <string-name><surname>Moench</surname><given-names>TR</given-names></string-name>, <string-name><surname>Cone</surname><given-names>RA</given-names></string-name></person-group>. <year>2011</year>. <article-title>In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide</article-title>. <source>BMC Infect Dis</source><volume>11</volume>:<fpage>200</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2334-11-200</pub-id>.<pub-id pub-id-type="pmid">21771337</pub-id></mixed-citation>
              </ref>
              <ref id="B51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lourenço</surname><given-names>A</given-names></string-name>, <string-name><surname>Pedro</surname><given-names>NA</given-names></string-name>, <string-name><surname>Salazar</surname><given-names>SB</given-names></string-name>, <string-name><surname>Mira</surname><given-names>NP</given-names></string-name></person-group>. <year>2018</year>. <article-title>Effect of acetic acid and lactic acid at low pH in growth and azole resistance of <italic toggle="yes">Candida albicans</italic> and <italic toggle="yes">Candida glabrata</italic></article-title>. <source>Front Microbiol</source><volume>9</volume>:<fpage>3265</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.03265</pub-id>.<pub-id pub-id-type="pmid">30671051</pub-id></mixed-citation>
              </ref>
              <ref id="B52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chaudry</surname><given-names>AN</given-names></string-name>, <string-name><surname>Travers</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Yuenger</surname><given-names>J</given-names></string-name>, <string-name><surname>Colletta</surname><given-names>L</given-names></string-name>, <string-name><surname>Evans</surname><given-names>P</given-names></string-name>, <string-name><surname>Zenilman</surname><given-names>JM</given-names></string-name>, <string-name><surname>Tummon</surname><given-names>A</given-names></string-name></person-group>. <year>2004</year>. <article-title>Analysis of vaginal acetic acid in patients undergoing treatment for bacterial vaginosis</article-title>. <source>J Clin Microbiol</source><volume>42</volume>:<fpage>5170</fpage>–<lpage>5175</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.42.11.5170-5175.2004</pub-id>.<pub-id pub-id-type="pmid">15528711</pub-id></mixed-citation>
              </ref>
              <ref id="B53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bai</surname><given-names>G</given-names></string-name>, <string-name><surname>Gajer</surname><given-names>P</given-names></string-name>, <string-name><surname>Nandy</surname><given-names>M</given-names></string-name>, <string-name><surname>Ma</surname><given-names>B</given-names></string-name>, <string-name><surname>Yang</surname><given-names>H</given-names></string-name>, <string-name><surname>Sakamoto</surname><given-names>J</given-names></string-name>, <string-name><surname>Blanchard</surname><given-names>MH</given-names></string-name>, <string-name><surname>Ravel</surname><given-names>J</given-names></string-name>, <string-name><surname>Brotman</surname><given-names>RM</given-names></string-name></person-group>. <year>2012</year>. <article-title>Comparison of storage conditions for human vaginal microbiome studies</article-title>. <source>PLoS One</source><volume>7</volume>:<elocation-id>e36934</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0036934</pub-id>.<pub-id pub-id-type="pmid">22655031</pub-id></mixed-citation>
              </ref>
              <ref id="B54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name><surname>Happel</surname><given-names>A-U</given-names></string-name>, <string-name><surname>Pidwell</surname><given-names>T</given-names></string-name>, <string-name><surname>Mendelsohn</surname><given-names>A</given-names></string-name>, <string-name><surname>Duyver</surname><given-names>M</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>L</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>L</given-names></string-name>, <string-name><surname>Slack</surname><given-names>C</given-names></string-name>, <string-name><surname>Strode</surname><given-names>A</given-names></string-name>, <string-name><surname>Mendel</surname><given-names>E</given-names></string-name>, <string-name><surname>Fynn</surname><given-names>L</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>M</given-names></string-name>, <string-name><surname>Spiegel</surname><given-names>H</given-names></string-name>, <string-name><surname>Jaspan</surname><given-names>H</given-names></string-name>, <string-name><surname>Passmore</surname><given-names>J-A</given-names></string-name>, <string-name><surname>Hosek</surname><given-names>S</given-names></string-name>, <string-name><surname>Smit</surname><given-names>D</given-names></string-name>, <string-name><surname>Rinehart</surname><given-names>A</given-names></string-name>, <string-name><surname>Bekker</surname><given-names>L-G</given-names></string-name></person-group>. <year>2020</year>. <article-title>An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose)</article-title>. <source>J Int AIDS Soc</source><volume>23</volume>:<elocation-id>e25626</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/jia2.25626</pub-id>.<pub-id pub-id-type="pmid">33034421</pub-id></mixed-citation>
              </ref>
              <ref id="B55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Workowski</surname><given-names>KA</given-names></string-name>, <string-name><surname>Bolan</surname><given-names>GA</given-names></string-name>, <collab>CDC</collab></person-group>. <year>2015</year>. <article-title>Sexually transmitted diseases treatment guidelines, 2015</article-title>. <source>MMWR Recomm Rep</source><volume>64</volume>:<fpage>1</fpage>–<lpage>137</lpage>.</mixed-citation>
              </ref>
              <ref id="B56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Hung</surname><given-names>G-C</given-names></string-name>, <string-name><surname>Nagamine</surname><given-names>K</given-names></string-name>, <string-name><surname>Li</surname><given-names>B</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>S</given-names></string-name>, <string-name><surname>Lo</surname><given-names>S-C</given-names></string-name></person-group>. <year>2016</year>. <article-title>Development of <italic toggle="yes">Candida</italic>-specific real-time PCR Assays for the detection and identification of eight medically important <italic toggle="yes">Candida</italic> species</article-title>. <source>Microbiol Insights</source><volume>9</volume>:<fpage>21</fpage>–<lpage>28</lpage>. doi:<pub-id pub-id-type="doi">10.4137/MBI.S38517</pub-id>.<pub-id pub-id-type="pmid">27103821</pub-id></mixed-citation>
              </ref>
              <ref id="B57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McMurdie</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Holmes</surname><given-names>S</given-names></string-name></person-group>. <year>2013</year>. <article-title>phyloseq: an R Package for reproducible interactive analysis and graphics of microbiome census data</article-title>. <source>PLoS One</source><volume>8</volume>:<elocation-id>e61217</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0061217</pub-id>.<pub-id pub-id-type="pmid">23630581</pub-id></mixed-citation>
              </ref>
              <ref id="B58">
                <label>58</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Gaujoux</surname><given-names>R</given-names></string-name></person-group>. <year>2014</year>. <source>Generating heatmaps for nonnegative matrix factorization.</source><publisher-name>R Foundation for Statistical Computing</publisher-name>, <publisher-loc>Vienna, Austria</publisher-loc>.</mixed-citation>
              </ref>
              <ref id="B59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Love</surname><given-names>MI</given-names></string-name>, <string-name><surname>Huber</surname><given-names>W</given-names></string-name>, <string-name><surname>Anders</surname><given-names>S</given-names></string-name></person-group>. <year>2014</year>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source><volume>15</volume>:<fpage>550</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>.<pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
